Medizinische Universität Graz - Research portal
Petru Edgar |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Lara, Gutierrez, A; Halbwedl, I; Sauer, S; Regitnig, P; Petru, E; Seeböck, R; Schubert, S; Peternell, C; Bodó, K; Prein, K; Kashofer, K
Robust assessment of HRD genomic instability by OncoScan microarrays.
J Mol Diagn. 2025;
Doi: 10.1016/j.jmoldx.2025.02.011
PubMed
FullText
FullText_MUG
** Rinnerthaler, G; Egle, D; Bartsch, R; Schmitt, CA; Petzer, A; Balic, M; Petru, E; Denison, U; Singer, CF; Bjelic-Radisic, V; Gampenrieder, SP; Knauer, M; Sotlar, K; Brunner, C; Posch, F; Hlauschek, D; Sölkner, L; Bago-Horvath, Z; Filipits, M; Gili, M; Ritter, M; Wieser, V; Albertini, C; Zaborsky, N; Weiss, L; Marhold, M; Schneeweiss, B; Pusch, R; Gnant, M; Greil, R
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Nat Cancer. 2025;
Doi: 10.1038/s43018-024-00890-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Singer, CF; Jahn, SW; Hlauschek, D; Heber, UM; Mang-Manger, C; Egle, D; Balic, M; Pichler, A; Pfeiler, G; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Petru, E; Greil, R; Bago-Horvath, Z; Deutschmann, C; Steger, GG; Seifert, M; Fitzal, F; Bartsch, R; Santhanagopal, A; Machacek-Link, J; Sellami, D; Schwarz, M; Fesl, C; Sölkner, L; Esker, S; Filipits, M; Gnant, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Cancer Commun (Lond). 2025;
Doi: 10.1002/cac2.12657
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Petru, E; Schinnerl, M; Kolovetsiou, V
Endometrial cancer-news from ASCO 2024
MEMO-MAG EUR MED ONC. 2025;
Doi: 10.1007/s12254-024-01022-3
Web of Science
FullText
FullText_MUG
Abstract (Journal)
** Baerens, DT; Guth, D; Göhler, T; Janni, W; Pluschnig, U; Zahn, MO; Wuerstlein, R; Vannier, C; Maass, N; Petru, E
Treatment of HER2+/HR+ early breast cancer with neratinib: selected patient cases from a retrospective single case report retrieval project
BREAST. 2025; 80: 103910
Doi: 10.1016/j.breast.2025.103910
Web of Science
FullText
FullText_MUG
2024
Full paper/article (Journal)
** Freyer, G; Martinez-Jañez, N; Kukielka-Budny, B; Ulanska, M; Bourgeois, H; Muñoz, M; Morales, S; Calero, JB; Cortesi, L; Pintér, T; Palácová, M; Cherciu, N; Petru, E; Ettl, J; de, Almeida, C; Villanova, G; Raymond, R; Minh, CTT; Rodrigues, A; Cazzaniga, ME
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Breast. 2024; 74:103681
Doi: 10.1016/j.breast.2024.103681
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lorusso, D; Xiang, Y; Hasegawa, K; Scambia, G; Leiva, M; Ramos-Elias, P; Acevedo, A; Cvek, J; Randall, L; Pereira, de, Santana, Gomes, AJ; Contreras, Mejía, F; Helpman, L; Akıllı, H; Lee, JY; Saevets, V; Zagouri, F; Gilbert, L; Sehouli, J; Tharavichitkul, E; Lindemann, K; Colombo, N; Chang, CL; Bednarikova, M; Zhu, H; Oaknin, A; Christiaens, M; Petru, E; Usami, T; Liu, P; Yamada, K; Toker, S; Keefe, SM; Pignata, S; Duska, LR, , ENGOT-cx11/GOG-3047/KEYNOTE-A18, investigators
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2024;
Doi: 10.1016/S0140-6736(24)01808-7
Web of Science
PubMed
FullText
FullText_MUG
** Schouten, PC; Schmidt, S; Becker, K; Thiele, H; Nürnberg, P; Richters, L; Ernst, C; Treilleux, I; Medioni, J; Heitz, F; Pisano, C; Garcia, Y; Petru, E; Hietanen, S; Colombo, N; Vergote, I; Nagao, S; Linn, SC; Pujade-Lauraine, E; Ray-Coquard, I; Harter, P; Hahnen, E; Schmutzler, RK
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
JAMA Netw Open. 2024; 7(4):e245552
Doi: 10.1001/jamanetworkopen.2024.5552
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Bartsch, R; Rinnerthaler, G; Petru, E; Egle, D; Gnant, M; Balic, M; Sliwa, T; Singer, C
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.
Wien Klin Wochenschr. 2024; 136(11-12):347-361
Doi: 10.1007/s00508-023-02254-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Chelariu-Raicu, A; Trillsch, F; Harter, P; Strobl, R; Sehouli, J; Wimberger, P; Bronger, H; Catherine, S; Lefeuvre, C; Rau, J; Hanker, L; Edgar, P; Heitz, F; Marme, F; El-Balat, A; Stockler, M; de Gregorio, N; Glasspool, R; Mahner, S; Lortholary, A; Pfisterer, J
Bevacizumab after prior anti-angiogenic Treatment in Female Patients with platinum-based Chemotherapy in Second-line Treatment of recurrent Ovarian Cancer - A Subgroup Analysis of Efficacy and Safety in AGOOVAR 2.21
GEBURTSH FRAUENHEILK. 2024; 84(6): E44-E45.
Doi: 10.1055/s-0044-1787414
[Poster]
Web of Science
FullText
FullText_MUG
** Guth, D; Göhler, T; Bäsecke, J; Tribian, N; Vannier, C; Maass, N; Petru, E
Retrospective single case reports on the treatment of patients with HER2-positive/HR-positive early breast cancer with neratinib
ONCOL RES TREAT. 2024; 47: 31-31.
[Poster]
Web of Science
** Harter, P; Wimberger, P; Okamoto, A; Reuss, A; Lim, MC; Rubio-Pérez, MJ; Vardar, MA; Scambia, G; Trédan, O; Hietanen, S; Colombo, N; Chudecka-Glaz, A; Petru, E; Lheureux, S; Van Nieuwenhuysen, E; Sehouli, J; Wenham, R; Ushijima, K; Indiviglio, S; Aghajanian, C
Durvalumab plus paclitaxel/carboplatin plus bevacizumab followed by durvalumab, bevacizumab plus olaparib maintenance among patients with newly-diagnosed advanced ovarian cancer without a tumor BRCA1/BRCA2 mutation: Updated results from DUO-O/ENGOT-OV46/GOG-3025 Trial
GYNECOL ONCOL. 2024; 190: S65-S66.
Doi: 10.1016/j.ygyno.2024.07.096
[Poster]
Web of Science
FullText
FullText_MUG
** Randall, L; Sukhin, V; Colombo, N; Korach, J; Matsumoto, T; Lalondrelle, S; Vizkeleti, J; Samouelian, V; Salani, R; Salman, P; Nogueira-Rodrigues, A; Ayhan, A; Frentzas, S; Cueva, J; Kim, YM; Petru, E; Milla, DP; Sehouli, J; Saevets, V; Yamada, K; Li, K; Szamreta, E; Nguyen, AM; Pignata, S; Lorusso, D
Patient-reported outcomes from the phase III, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/ KEYNOTE-A18 Study of pembrolizumab plus concurrent chemoradiotherapy among patients with high-risk, locally advanced cervical cancer
GYNECOL ONCOL. 2024; 190: S9-S9.
[Poster]
Web of Science
** Singer, CF; Hlauschek, D; Pfeiler, G; Egle, D; Bartsch, R; Suppan, C; Pichler, A; Petru, E; Greil, R; Rudas, M; Seifert, M; Petzer, A; Fitzal, F; Bago-Horvath, Z; Filipits, M; Soelkner, L; Fesl, C; Gnant, M
Addition of the MUC-1 vaccine tecemotide to neoadjuvant systemic therapy for patients with early breast cancer: Survival results from the prospective randomized ABCSG 34 trial
J CLIN ONCOL. 2024; 42(16):
[Poster]
Web of Science
2023
Full paper/article (Journal)
** Emons, G; Steiner, E; Vordermark, D; Uleer, C; Paradies, K; Tempfer, C; Aretz, S; Cremer, W; Hanf, V; Mallmann, P; Ortmann, O; Römer, T; Schmutzler, RK; Horn, LC; Kommoss, S; Lax, S; Schmoeckel, E; Mokry, T; Grab, D; Reinhardt, M; Steinke-Lange, V; Brucker, SY; Kiesel, L; Witteler, R; Fleisch, MC; Prömpeler, H; Friedrich, M; Höcht, S; Lichtenegger, W; Mueller, M; Runnebaum, I; Feyer, P; Hagen, V; Juhasz-Böss, I; Letsch, A; Niehoff, P; Zeimet, AG; Battista, MJ; Petru, E; Widhalm, S; van Oorschot, B; Panke, JE; Weis, J; Dauelsberg, T; Haase, H; Beckmann, MW; Jud, S; Wight, E; Prott, FJ; Micke, O; Bader, W; Reents, N; Henscher, U; Tholen, R; Schallenberg, M; Rahner, N; Mayr, D; Kreissl, M; Lindel, K; Mustea, A; Strnad, V; Goerling, U; Bauerschmitz, GJ; Langrehr, J; Neulen, J; Ulrich, UA; Nothacker, MJ; Blödt, S; Follmann, M; Langer, T; Wenzel, G; Weber, S; Erdogan, S
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures
GEBURTSH FRAUENHEILK. 2023; 83(08): 919-961.
Doi: 10.1055/a-2066-2051
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Herzog, EM; Pirmorady, Sehouli, A; Boer, J; Pietzner, K; Petru, E; Heinzelmann, V; Roser, E; Dimitrova, D; Oskay-Özcelik, G; Camara, O; Sehouli, J
How to break bad news and how to learn this skill: results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians andthe physicians are generally alone with the patient; only 57.4% medical students with 1089 participants.
Int J Gynecol Cancer. 2023; 33(12):1934-1942
Doi: 10.1136/ijgc-2023-004693
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kurtz, JE; Pujade-Lauraine, E; Oaknin, A; Belin, L; Leitner, K; Cibula, D; Denys, H; Rosengarten, O; Rodrigues, M; de Gregorio, N; García, JM; Petru, E; Kocián, R; Vergote, I; Pautier, P; Schmalfeldt, B; Gaba, L; Polterauer, S; Reynier, MAM; Sehouli, J; Churruca, C; Selle, F; Joly, F; D'Hondt, V; Bultot-Boissier, E; Lebreton, C; Lotz, JP; Largillier, R; Heudel, PE; Heitz, F
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
J CLIN ONCOL. 2023; 41(30): 4768-+.
Doi: 10.1200/JCO.23.00529
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pujade-Lauraine, E; Brown, J; Barnicle, A; Wessen, J; Lao-Sirieix, P; Criscione, SW; du, Bois, A; Lorusso, D; Romero, I; Petru, E; Yoshida, H; Vergote, I; Colombo, N; Hietanen, S; Provansal, M; Schmalfeldt, B; Pignata, S; Martín, Lorente, C; Berton, D; Runnebaum, IB; Ray-Coquard, I
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
JCO Precis Oncol. 2023; 7:e2200258
Doi: 10.1200/PO.22.00258
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Colombo, N; Harano, K; Hudson, E; Galli, F; Antill, Y; Choi, CH; Rabaglio, M; Marmé, F; Petru, E; Lai, CH; Biagioli, E; Madrid, LF; Takehara, K; Allan, K; Lee, YC; Piovano, E; Zamagni, C; Tasca, G; Ferrero, A; Ginesta, MPB
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma
ANN ONCOL. 2023; 34: S1281-S1282.
Doi: 10.1016/j.annonc.2023.10.034
[Poster]
Web of Science
FullText
FullText_MUG
** Heitz, F; Petru, E; Henry, S; Reuss, A; Cibula, D; Gaba, L; Colombo, N; Polleis, S; Harter, P
AGO-OVAR 28/ENGOT-OV57: NIRAPARIB VS NIRAPARIB IN COMBINATION WITH BEVACIZUMAB IN PATIENTS WITH CARBOPLATIN-TAXANE BASED CHEMOTHERAPY IN ADVANCED OVARIAN CANCER (A MULTICENTRE RANDOMISED PHASE III TRIAL)
INT J GYNECOL CANCER. 2023; 33: A413-A413.
Doi: 10.1136/ijgc-2023-ESGO.875
Web of Science
FullText
FullText_MUG
** Kolovetsiou-Kreiner, V; Greimel, E; Bliem, B; Petru, E; Tamussino, K; Trutnovsky, G
"Breaking bad news" - an exploratory clinical interview Study
GEBURTSH FRAUENHEILK. 2023; 83(4): 6-7.
Doi: 10.1055/s-0043-1766405
[Poster]
Web of Science
FullText
FullText_MUG
** Pesto, LA; Bracic, T; Neumeister, P; Petru, E
Clinical Manifestation of female Genital Lymphoma: a retrospective Analysis of 28 Cases over 31 Years
GEBURTSH FRAUENHEILK. 2023; 83(4): 8-8.
Doi: 10.1055/s-0043-1766408
[Poster]
Web of Science
FullText
FullText_MUG
** Tribian, N; Göhler, T; Bäsecke, J; Guth, D; Vannier, C; Petru, E; Maass, N
Retrospective single case reports on the treatment of patients with HER2-positive/HR-positive early breast cancer with neratinib (IRENE)
ONCOL RES TREAT. 2023; 46: 171-171.
[Poster]
Web of Science
2022
Full paper/article (Journal)
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)
EUR J CANCER. 2022; 166: 126-133. Doi: 10.1016/j.ejca.2022.01.028
Web of Science PubMed FullText FullText_MUG
** Bartsch, R; Gampenrieder, SP; Rinnerthaler, G; Petru, E; Egle, D; Petzer, A; Balic, M; Pluschnig, U; Sliwa, T; Singer, C
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
Wien Klin Wochenschr. 2022; 134(1-2):63-72
Doi: 10.1007/s00508-021-01987-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Denschlag, D; Ackermann, S; Battista, MJ; Cremer, W; Egerer, G; Fehr, M; Follmann, M; Haase, H; Harter, P; Hettmer, S; Horn, LC; Juhasz-Boess, I; Kast, K; Köhler, G; Kröncke, T; Lindel, K; Mallmann, P; Meyer-Steinacker, R; Mustea, A; Petru, E; Reichardt, P; Schmidt, D; Strauss, HG; Thiel, F; Ulrich, UA; Vogl, T; Vordermark, D; Wallwiener, M; Gass, P; Beckmann, MW
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021).
Geburtshilfe Frauenheilkd. 2022; 82(12):1337-1367
Doi: 10.1055/a-1897-5124
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kashofer, K; Regauer, S; Reich, O; Petru, E; Winter, E
Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Gynecol Oncol. 2022; 165(1):121-128
Doi: 10.1016/j.ygyno.2022.01.020
Web of Science
PubMed
FullText
FullText_MUG
** Mallmann, P; Vordermark, D; Feyer, P; Hagen, V; Hocht, S; Niehoff, P; Petru, E; Zeimet, AG; Micke, O; Battista, MJ
Adjuvant therapy of endometrial cancer
GYNAKOLOGIE. 2022; 55(7): 501-508.
Doi: 10.1007/s00129-022-04959-w
Web of Science
FullText
FullText_MUG
** Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grünberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.
Wien Klin Wochenschr. 2022; 134(19-20):683-692
Doi: 10.1007/s00508-022-02082-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zhou, Q; Gampenrieder, SP; Frantal, S; Rinnerthaler, G; Singer, CF; Egle, D; Pfeiler, G; Bartsch, R; Wette, V; Pichler, A; Petru, E; Dubsky, PC; Bago-Horvath, Z; Fesl, C; Rudas, M; Ståhlberg, A; Graf, R; Weber, S; Dandachi, N; Filipits, M; Gnant, M; Balic, M; Heitzer, E
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res. 2022; 28(4):697-707
Doi: 10.1158/1078-0432.CCR-21-3231
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Petru, E
Endometrial cancer: news from ASCO
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00844-3
Web of Science
FullText
FullText_MUG
Abstract (Journal)
** Alt, I; Shelke, R; Lobley, A; Baumgaertler, C; Stulic, M; Fons, P; Whittaker, M; Hackner, K; Dzurillova, L; Petru, E; Hadjari, L; Lafleur, J; Singer, J; Krall, N; Hefler, L; Fureder, T; Taubert, C; Boudesco, C; Payne, A; Vladimer, GI
Enriching for adenosine antagonist patient responses through deep learning
CANCER RES. 2022; 82(12):
Web of Science
** Gutierrez-Perez, I; Van Ham, J; Aranha, V; Okumura, R; Waltenberger, E; Alt, I; Baumgaertler, C; Stulic, M; Petru, E; Minichsdorfer, C; Hefler, L; Lafleur, J; Krall, N; Fureder, T; Vladimer, GI; Sehlke, R; Vilagos, B
Deep learning supported high content analysis of primary patient samples identifies ALK inhibition as a novel mechanism of action in a subset of ovarian cancers
CANCER RES. 2022; 82(12):
Web of Science
** Kurtz, JE; Anota, A; Cropet, C; Priou, F; Harter, P; Pignata, S; Palacio, I; Petru, E; Kobayashi, H; Vuylsteke, P; Parma, G; Maenpaa, J; Raymond, E; Buderath, P; Lorusso, D; Herrero, A; Raban, N; Pujade-Lauraine, E; Joly, F; Ray-Coquard, IL
Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).
J CLIN ONCOL. 2022; 40(16):
[Poster]
Web of Science
** Singer, CF; Egle, D; Greil, R; Petru, E; Ohler, L; Balic, M; Tinchon, C; Pfeiler, G; Marhold, M; Brunner, C; Haider, K; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Uthman, S; Mraz, B; Bartsch, R
REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
ANN ONCOL. 2022; 33: S217-S217.
Doi: 10.1016/j.annonc.2022.03.214
[Poster]
Web of Science
FullText
FullText_MUG
** Somlyay, M; Durinikova, E; Besnard, J; Barbeau, O; Le Coz, J; Senekowitsch, M; Erguner, B; Hackner, K; Dzurillova, L; Petru, E; Lafleur, J; Singer, J; Fureder, T; Paveley, R; Joseph, J; Aswad, F; Winkler-Penz, T; Sehlke, R; Boudesco, C; Vladimer, G
Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling
EUR J CANCER. 2022; 174: S44-S45.
[Poster]
Web of Science
2021
Full paper/article (Journal)
** Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Br J Cancer. 2021; 124(11): 1795-1802.
Doi: 10.1038/s41416-021-01284-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Hubalek, M; Petru, E; Sandholzer, M; Andel, J; Balic, M; Melchardt, T; Hauser-Kronberger, C; Schmitt, CA; Ulmer, H; Greil, R
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
Ther Adv Med Oncol. 2021; 13:17588359211042301
Doi: 10.1177/17588359211042301
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Taumberger, N; Laky, R; Schutz, AM; Bracic, T; Petru, E; Bader, A; Aigmuller, T; Trutnovsky, G; Tamussino, K
'QUICK' LAPAROSCOPY FOR SUSPECTED ADVANCED OVARIAN CANCER
INT J GYNECOL CANCER. 2021; 31: A110-A110.
Doi: 10.1136/ijgc-2021-IGCS.274
[Poster]
Web of Science
FullText
FullText_MUG
** Taumberger, NA; Bracic, T; Tamussino, K; Petru, E
Bone Metastasis 10 Years after radical Trachelectomy and systematic pelvic Lymphadenectomy for early Cervical Carcinoma: a Case Report
GEBURTSH FRAUENHEILK. 2021; 81(04):E7-E7.-AGO Jahrestagung; NOV-28-2022; Virtuell.
Doi: 10.1055/s-0041-1726596
[Poster]
Web of Science
FullText
FullText_MUG
** Tsibulak, I; Reiser, E; Bogner, G; Petru, E; Hell-Teutsch, J; Reinthaller, A; Weirather, C; Weiss, T; Bozsa, S; Puschacher, B; Hall, M; Hittler, D; Hrauda, K; Thell, E; Clauss, S; Pozniak, J; Alicke, S; Gangl, D; Gamperl, G; Ebner, C; Knoll, K; Leitner, K; Schilcher, A; Schinnerl, M; Sigl, V; Singer, C; Aigmuller, T; Hofstatter, B; Marth, C
Decrease in Tumor Audio Diagnoses at gynaecology Departments during the COVID-19 Pandemic
GEBURTSH FRAUENHEILK. Kongressabstracts. 2021; 81(04):E1-E1.-XXIX. Wissenschaftlichen Tagung der AGO der OEGGG) und zum 18.
Österreichischen Kongress „Krebs bei der Frau“; APR 15-17, 2021; Virtuell.
Doi: 10.1055/s-0041-1726578
[Poster]
Web of Science
FullText
FullText_MUG
2020
Full paper/article (Journal)
** Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M; Austrian Breast and Colorectal Cancer Study Group
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer. 2020; 134:99-106
Doi: 10.1016/j.ejca.2020.04.020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Harter, P; Pautier, P; Van Nieuwenhuysen, E; Reuss, A; Redondo, A; Lindemann, K; Kurzeder, C; Petru, E; Heitz, F; Sehouli, J; Degregorio, N; Wimberger, P; Burges, A; Cron, N; Ledermann, J; Lorusso, D; Paoletti, X; Marme, F
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).
Int J Gynecol Cancer. 2020; 30(12): 1997-2001.
Doi: 10.1136/ijgc-2020-001572
Web of Science
PubMed
FullText
FullText_MUG
** Hurvitz, SA; Martin, M; Press, MF; Chan, D; Fernandez-Abad, M; Petru, E; Rostorfer, R; Guarneri, V; Huang, CS; Barriga, S; Wijayawardana, S; Brahmachary, M; Ebert, PJ; Hossain, A; Liu, J; Abel, A; Aggarwal, A; Jansen, VM; Slamon, DJ
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer.
CLIN CANCER RES. 2020; 26(3): 566-580.
Doi: 10.1158/1078-0432.CCR-19-1425
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stöger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Maria Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M; Austrian Breast & Colorectal Cancer Study Group
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Eur J Cancer. 2020; 132:43-52
Doi: 10.1016/j.ejca.2020.03.018
Web of Science
PubMed
FullText
FullText_MUG
** Steger, GG; Egle, D; Bartsch, R; Pfeiler, G; Petru, E; Greil, R; Helfgott, R; Marth, C; Öhler, L; Hubalek, M; Lang, A; Tinchon, C; Haslbauer, F; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Gnant, M
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.
Breast. 2020; 50:64-70
Doi: 10.1016/j.breast.2020.01.035
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tsibulak, I; Reiser, E; Bogner, G; Petru, E; Hell-Teutsch, J; Reinthaller, A; Weirather, C; Weiss, T; Bozsa, S; Puschacher, B; Hall, M; Hittler, D; Hrauda, K; Thell, E; Clauss, S; Pozniak, J; Alicke, S; Gangl, D; Gamperl, G; Ebner, C; Knoll, K; Leitner, K; Schilcher, A; Schinnerl, M; Sigl, V; Singer, C; Aigmüller, T; Hofstätter, B; Marth, C
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
Int J Gynecol Cancer. 2020; 30(11):1667-1671
Doi: 10.1136/ijgc-2020-001975
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Correction
** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2020; 11(1): 1965-1965.
Doi: 10.1038/s41467-020-15799-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Hochstatter, R; Taumberger, N; Schutz, AM; Trapp, E; Pfniss, I; Petru, E
Interfaces of gynaecological Oncology with Neurology - a Case Series.
GEBURTSH FRAUENHEILK. 2020; 80(06):E17-E17.-Jahrestagung 2020 der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG); JUN 10-13, 2020; Graz, AUSTRIA.
Doi: 10.1055/s-0040-1713235
Web of Science
FullText
FullText_MUG
** Kirchhoff, E; Petru, E; Tamussino, K; Jahn, SW; Regitnig, P
Mucinous Ovarian Cancer: A separate Entity.
GEBURTSH FRAUENHEILK. 2020; 80(4):438-439.-XXVIII. Wissenschaftliche Tagung der Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) der OEGGG 2020
; APR 23-25,2020; Salzburg, AUSTRIA.
Doi: 10.1055/s-0039-3403410
[Poster]
Web of Science
FullText
FullText_MUG
** Singer, CF; Egle, D; Greil, R; Ohler, L; Petru, E; Suppan, C; Marhold, M; Pfeiler, G; Brunner, C; Tinchon, C; Halper, S; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Hennebelle, M; Mraz, B; Bartsch, R
REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC).
ANN ONCOL. 2020; 31: S77-S78.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.03.272
[Oral Communication]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Taumberger, N; Hochstatter, R; Schutz, AM; Trapp, E; Pfniss, I; Petru, E
Significant neurological-psychiatric Symptoms in six consecutive Patients with gynecological Malignancies - a Case Series.
GEBURTSH FRAUENHEILK. Kongressabstracts zur Wissenschaftlichen Tagung der Arbeitsgemeinschaft für gynäkologische Onkologie (AGO) der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG). 2020; 80(4):437-437.-Tagung der Arbeitsgemeinschaft für gynäkologische Onkologie (AGO) der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG); MAI 8-11, 2020; Salzburg, AUSTRIA.
Doi: 10.1055/s-0039-3403406
Web of Science
FullText
FullText_MUG
** Trapp, E; Kolovetsiou-Kreiner, V; Reisinger, J; Bramreiter, V; Speicher, M; Geigl, J; Petru, E; Tamussino, K; Pristauz, G
Multiple Gene analysis in Breast and Ovarian Cancer Patients.
GEBURTSH FRAUENHEILK. Kongressabstracts zur Wissenschaftlichen Tagung der Arbeitsgemeinschaft für gynäkologische Onkologie (AGO) der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG). 2020; 80(4):436-436.-Tagung der Arbeitsgemeinschaft für gynäkologische Onkologie (AGO) der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG); MAI 8-11, 2020; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Trapp, EK; Speicher, M; Geigl, JB; Kolovetsiou-Kreiner, V; Reisinger, J; Haas, J; Petru, E; Tamussino, K; Pristauz, G
Multigene panel analysis in breast and ovarian cancer.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS19-P5-03-09
[Poster]
Web of Science
FullText
FullText_MUG
** van der Merwe, J; Petru, E
CDK 4/6 Inhibition in life-threatening visceral Metastasis of occult Breast Cancer.
GEBURTSH FRAUENHEILK. Kongressabstracts zur Jahrestagung 2020 der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG). 2020; 80(06):E19-E19.-Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG); JUN 10-13, 2020; Graz, AUSTRIA.
Doi: 10.1055/s-0040-1713239
[Poster]
Web of Science
FullText
FullText_MUG
2019
Full paper/article (Journal)
** Bjelic-Radisic, V; Singer, C; Tamussino, K; Kölbl, H; Petru, E; Volgger, B; Polterauer, S; Oppelt, P; Sevelda, P; Bogner, G; Marth, C; Austrian Gynecologic Oncology Working Group
Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology.
Wien Klin Wochenschr. 2019; 131(9-10): 233-236.
Doi: 10.1007/s00508-019-1468-7
Web of Science
PubMed
FullText
FullText_MUG
** Cazzaniga, ME; Munzone, E; Bocci, G; Afonso, N; Gomez, P; Langkjer, S; Petru, E; Pivot, X; Sánchez Rovira, P; Wysocki, P; Torri, V
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project.
ADV THER. 2019; 36(2): 381-406.
Doi: 10.1007/s12325-018-0844-4
Web of Science
PubMed
FullText
FullText_MUG
** Denschlag, D; Ackermann, S; Battista, MJ; Cremer, W; Egerer, G; Follmann, M; Haas, H; Harter, P; Hettmer, S; Horn, LC; Juhasz-Boess, I; Kast, K; Köhler, G; Kröncke, T; Lindel, K; Mallmann, P; Meyer-Steinacker, R; Mustea, A; Petru, E; Reichardt, P; Schmidt, D; Strauss, HG; Tempfer, C; Thiel, F; Ulrich, U; Vogl, T; Vordermark, D; Gass, P; Beckmann, MW
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019).
Geburtshilfe Frauenheilkd. 2019; 79(10):1043-1060
Doi: 10.1055/a-0882-4116
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666.
Doi: 10.1038/s41467-019-12714-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Case Report
** Lakovschek, IC; Petru, E; Pollheimer, MJ; Ratschek, M; Augustin, H; Bjelic-Radisic, V
A rare case of cancer-to-cancer metastasis: breast cancer to renal cell cancer : Case report and review of literature.
Wien Med Wochenschr. 2019; 169(13-14):350-353
Doi: 10.1007/s10354-019-0694-y
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Fujiwara, K; Harter, P; Leary, A; Perol, D; Pignata, S; Gonzalez-Martin, A; Petru, E; van Nieuwenhuysen, E; Colombo, N; Maenpaa, J; Selle, F; de Gregorio, N; Lorusso, D; Alia, EMG; Lefeuvre-Plesse, C; Buderath, P; Lortholary, A; Burges, A; Pujade-Lauraine, E; Ray-Coquard, IL
Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) Asia Congress; NOV 22-24, 2019; Singapore, SINGAPORE.
[Keynote lecture]
Web of Science
** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Voskova, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R
Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
CANCER RES. 2019; 79(4):-San Antonio Breast Cancer Symposium; DEC 04-08, 2018; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS18-OT3-07-01
[Poster]
Web of Science
FullText
FullText_MUG
** Singer, CF; Oehler, L; Egle, D; Greil, R; Petru, E; Balic, M; Marhold, M; Pfeiler, G; Brunner, C; Kwasny, W; Galid, AA; Tinchon, C; Eisterer, W; Haslbauer, F; Hubalek, M; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Steger, GG
REACHAUT: First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) in the real-world setting.
J CLIN ONCOL. 2019; 37(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 31-JUN 04, 2019; Chicago, IL.
Doi: 10.1200/JCO.2019.37.15_suppl.e12527
[Poster]
Web of Science
FullText
FullText_MUG
** Steger, G; Galid, A; Rechberger, E; Eisterer, W; Herz, W; Petru, E; Pasterk, C; Girschikofsky, M; Singer, C; Grunberger, B; Stoger, H; Marhold, M; Hitzl, D; Lindegger, N
Exploring real world data treatment patterns and outcomes in participants with HER2+unresectable LA/mBC - Austrian participation in the prospective European registry SAMANTHA study
ONCOL RES TREAT. 2019; 42: 41-42.
Web of Science
2018
Full paper/article (Journal)
** Emons, G; Steiner, E; Vordermark, D; Uleer, C; Bock, N; Paradies, K; Ortmann, O; Aretz, S; Mallmann, P; Kurzeder, C; Hagen, V; van Oorschot, B; Höcht, S; Feyer, P; Egerer, G; Friedrich, M; Cremer, W; Prott, FJ; Horn, LC; Prömpeler, H; Langrehr, J; Leinung, S; Beckmann, MW; Kimmig, R; Letsch, A; Reinhardt, M; Alt-Epping, B; Kiesel, L; Menke, J; Gebhardt, M; Steinke-Lange, V; Rahner, N; Lichtenegger, W; Zeimet, A; Hanf, V; Weis, J; Mueller, M; Henscher, U; Schmutzler, RK; Meindl, A; Hilpert, F; Panke, JE; Strnad, V; Niehues, C; Dauelsberg, T; Niehoff, P; Mayr, D; Grab, D; Kreißl, M; Witteler, R; Schorsch, A; Mustea, A; Petru, E; Hübner, J; Rose, AD; Wight, E; Tholen, R; Bauerschmitz, GJ; Fleisch, M; Juhasz-Boess, I; Lax, S; Runnebaum, I; Tempfer, C; Nothacker, MJ; Blödt, S; Follmann, M; Langer, T; Raatz, H; Wesselmann, S; Erdogan, S
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.
Geburtshilfe Frauenheilkd. 2018; 78(11):1089-1109
Doi: 10.1055/a-0715-2964
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Emons, G; Steiner, E; Vordermark, D; Uleer, C; Bock, N; Paradies, K; Ortmann, O; Aretz, S; Mallmann, P; Kurzeder, C; Hagen, V; van Oorschot, B; Höcht, S; Feyer, P; Egerer, G; Friedrich, M; Cremer, W; Prott, FJ; Horn, LC; Prömpeler, H; Langrehr, J; Leinung, S; Beckmann, MW; Kimmig, R; Letsch, A; Reinhardt, M; Alt-Epping, B; Kiesel, L; Menke, J; Gebhardt, M; Steinke-Lange, V; Rahner, N; Lichtenegger, W; Zeimet, A; Hanf, V; Weis, J; Mueller, M; Henscher, U; Schmutzler, RK; Meindl, A; Hilpert, F; Panke, JE; Strnad, V; Niehues, C; Dauelsberg, T; Niehoff, P; Mayr, D; Grab, D; Kreißl, M; Witteler, R; Schorsch, A; Mustea, A; Petru, E; Hübner, J; Rose, AD; Wight, E; Tholen, R; Bauerschmitz, GJ; Fleisch, M; Juhasz-Boess, I; Sigurd, L; Runnebaum, I; Tempfer, C; Nothacker, MJ; Blödt, S; Follmann, M; Langer, T; Raatz, H; Wesselmann, S; Erdogan, S
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.
Geburtshilfe Frauenheilkd. 2018; 78(10):949-971
Doi: 10.1055/a-0713-1218
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Friedlander, M; Rau, J; Lee, CK; Meier, W; Lesoin, A; Kim, JW; Poveda, A; Buck, M; Scambia, G; Shimada, M; Hilpert, F; King, MT; Debruyne, P; Bologna, A; Malander, S; Monk, BJ; Petru, E; Calvert, P; Herzog, TJ; Barrett, C; du Bois, A
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
ANN ONCOL. 2018; 29(3): 737-743.
Doi: 10.1093/annonc/mdx796
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mallmann, P; Hocht, S; Vordermark, D; Zeimet, AG; Petru, E; Feyer, P; Letsch, A; Hagen, V
Adjuvant therapy of endometrial cancer
GYNAKOLOGE. 2018; 51(12): 1032-1036.
Doi: 10.1007/s00129-018-4332-3
Web of Science
FullText
FullText_MUG
** Petru, E; Huber, C; Sampl, E; Haas, J
Comparison of Primary Tumor Size in Stage I and III Epithelial Ovarian Cancer.
Anticancer Res. 2018; 38(11):6507-6511
Doi: 10.21873/anticanres.13015
Web of Science
PubMed
FullText
FullText_MUG
** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC Cancer. 2018; 18(1):1074
Doi: 10.1186/s12885-018-4979-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** de Wit, M; Angermeier, S; Groschek, M; von Weikersthal, LF; Roitner, F; Strittmatter, HJ; Tome, O; Petru, E; Rauter, M; Randerath, W; Abenhardt, W; Bischoff, J; Egert, M; Eschenburg, H; Krause, G; Schem, C; Edlich, B; Singer, C; Jakob, A
Interim analysis of the non-interventional study (NIS) "StepUp" assessing initial dosing schedules of oral vinorelbine in patients with advanced non-small-cell lung cancer (NSCLC) or metastatic breast cancer (MBC) in clinical routine in Germany and Austria
ONCOL RES TREAT. . 2018; 41: 50-50.-33. Deutscher Krebskongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
** Dubsky, PC; Fesl, C; Singer, CF; Pfeiler, G; Kronenwett, R; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, MKM; Wette, V; Petzner, AL; Sevelda, P; Egle, D; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Lax, S; Regitnig, P; Gnant, M; Filipits, M
The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2-breast cancer patients from ABCSG 34
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Oral Communication]
Web of Science
** Martin, M; Hurvitz, SA; Chan, D; Fernandez-Abad, M; Petru, E; Rostorfer, R; Guarneri, V; Huang, CS; Press, MF; Costigan, TM; Caldwell, CW; Wijayawardana, S; Turner, PK; Barriga, S; Slamon, DJ
Final results of NeoMONARCH: A phase 2 neoadjuvant study of abemaciclib in postmenopausal women with hormone receptor positive (HR+), HER2 negative breast cancer (BC)
CANCER RES. . 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Poster]
Web of Science
** Roitner, F; Angermeier, S; de Wit, M; Groschek, M; von Weikersthal, LF; Tome, O; Petru, E; Strittmatter, HJ; Rauter, M; Bischoff, J; Randerath, WJ; Schem, C; van Mackelenbergh, M; Edlich, B; Jakob, A; Singer, CF
Final analysis of the non-interventional study (NIS) "StepUp" assessing dosing schedules of oral vinorelbine in patients with advanced non-small cell lung cancer (NSCLC) or metastatic breast cancer (MBC) in clinical routine in Germany and Austria
ONCOL RES TREAT. . 2018; 41: 223-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28-OCT 2, 2018; Vienna, AUSTRIA.
[Poster]
Web of Science
** Steger, G; Petru, E; Haslbauer, F; Marth, C; Egle, D; Galid, A; Sliwa, T; Lang, A; Kuehr, T; Petzer, A; Ruckser, R; Greil, R; Mlineritsch, B; Singer, C; Seifert, M; Andel, J; Kwasny, W; Pichler, P; Tinchon, C; Bartsch, R
Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer
EUR J CANCER. . 2018; 92: S97-S97.-11th European Breast Cancer Conference (EBCC); MAR 21-23, 2018; Barcelona, SPAIN.
[Poster]
Web of Science
2017
Full paper/article (Journal)
** Bekos, C; Grimm, C; Brodowicz, T; Petru, E; Hefler, L; Reimer, D; Koch, H; Reinthaller, A; Polterauer, S; Polterauer, M
Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma - a multicenter study.
Sci Rep. 2017; 7(1):14474-14474
Doi: 10.1038/s41598-017-13934-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Singer, CF; Tan, YY; Fitzal, F; Steger, GG; Egle, D; Reiner, A; Rudas, M; Moinfar, F; Gruber, C; Petru, E; Bartsch, R; Tendl, KA; Fuchs, D; Seifert, M; Exner, R; Balic, M; Bago-Horvath, Z; Filipits, M; Gnant, M; Austrian Breast and Colorectal Cancer Study Group
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.
Clin Cancer Res. 2017; 23(14):3676-3683
Doi: 10.1158/1078-0432.CCR-16-2373
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zeimet, AG; Mori, H; Petru, E; Polterauer, S; Reinthaller, A; Schauer, C; Scholl-Firon, T; Singer, C; Wimmer, K; Zschocke, J; Marth, C
AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS).
ARCH GYNECOL OBSTET. 2017; 296(1): 123-127.
Doi: 10.1007/s00404-017-4392-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bekos, C; Petru, E; Hefler, L; Reimer, D; Koch, H; Polterauer, S
PROGNOSTIC ROLE OF PLASMA FIBRINOGEN IN PATIENTS WITH UTERINE LEIOMYOSARCOMA - A MULTICENTER STUDY
INT J GYNECOL CANCER. . 2017; 27: 1299-1299.
[Poster]
Web of Science
** Bjelic-Radisic, V; Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoger, H; Pichler, A; Petru, E; Greil, R; Wette, V; Petzer, A; Sevelda, P; Egle, D; Dubsky, P; Fitzal, F; Jakesz, R; Balic, M; Frantal, S; Solkner, L; Gnant, M
Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax (R)) in the preoperative treatment of women with primary breast cancer (ABCSG-34)
ANN ONCOL. 2017; 28: -42nd European-Society-for-Medical-Oncology Congress (ESMO); SEP 08-12, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
** Fasching, PA; Abad, MF; Garcia-Saenz, JA; Schneeweiss, A; Guarneri, V; Colleoni, M; Petru, E; Costigan, TM; Caldwell, CW; Barriga, S; Hurvitz, S; Slamon, D
Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2-breast cancer.
ONCOL RES TREAT. 2017; 40: 225-226.-SABCS; 8.12.2017; San Antonio, USA.
[Oral Communication]
Web of Science
** Guarneri, V; Fasching, PA; Abad, MF; Garcia-Saenz, A; Schneeweiss, A; Colleoni, M; Petru, E; Costigan, TM; Caldwell, CW; Barriga, S; Hurvitz, S; Slamon, D
Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2-breast cancer
ANN ONCOL. 2017; 28: 19-19.-19th National Congress of Medical Oncology; OCT 27-29, 2017; Rome, ITALY.
[Poster]
Web of Science
** Hurvitz, S; Martin, M; Abad, MF; Chan, D; Rostorfer, R; Petru, E; Barriga, S; Costigan, TM; Caldwell, CW; Nguyen, T; Press, M; Slamo, D
Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2-breast cancer
CANCER RES. 2017; 77: -San Antonio Breast Cancer Symposium; DEC 06-10, 2016; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS16-S4-06
[Keynote lecture]
Web of Science
FullText
FullText_MUG
** Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)
CANCER RES. 2017; 77: -San Antonio Breast Cancer Symposium; DEC 06-10, 2016; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS16-P5-15-13
[Poster]
Web of Science
FullText
FullText_MUG
** Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Greil, R; Rudas, M; Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Michael, G
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)
CANCER RES. 2017; 77: -San Antonio Breast Cancer Symposium; DEC 06-10, 2016; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS16-P6-10-01
[Poster]
Web of Science
FullText
FullText_MUG
** Steger, GG; Bartsch, R; Pfeiler, G; Petru, E; Greil, R; Helfgott, R; Egle, D; Ohler, L; Lang, A; Tinchon, C; Haslbauer, F; Redl, A; Hennebelle, M; Mraz, B; Winiger-Candolfi, I; Gnant, M
Efficacy and safety of everolimus plus exemestane in HR+, HER2-advanced breast cancer progressing on/after prior endocrine therapy, in routine clinical practice: 2nd interim analysis from STEPAUT
CANCER RES. 2017; 77: -San Antonio Breast Cancer Symposium; DEC 06-10, 2016; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS16-P4-22-20
[Poster]
Web of Science
FullText
FullText_MUG
2016
Full paper/article (Journal)
** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155
Doi: 10.1007/978-3-319-42044-8_28
Web of Science
PubMed
FullText
FullText_MUG
** Schwameis, R; Grimm, C; Brodowicz, T; Petru, E; Hefler-Frischmuth, K; Staudigl, C; Reinthaller, A; Heinze, G; Polterauer, S; Polterauer, M
Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma.
Sci Rep. 2016; 6(5):33757-33757
Doi: 10.1038/srep33757
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sehouli, J; Chekerov, R; Reinthaller, A; Richter, R; Gonzalez-Martin, A; Harter, P; Woopen, H; Petru, E; Hanker, LC; Keil, E; Wimberger, P; Klare, P; Kurzeder, C; Hilpert, F; Belau, AK; Zeimet, A; Bover-Barcelo, I; Canzler, U; Mahner, S; Meier, W
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Ann Oncol. 2016; 27(12):2236-2241
Doi: 10.1093/annonc/mdw418
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR
Inferring expressed genes by whole-genome sequencing of plasma DNA.
Nat Genet. 2016; 48(10):1273-1278
Doi: 10.1038/ng.3648
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** De la Haba, J; Cazzaniga, M; Freyer, G; Costa, L; Petru, E; Bartsch, R; Staroslawska, E; de Almeida, C; Villanova, G; Cardoso, F
Randomised phase II study evaluating, as first-line chemotherapy, single-agent oral vinorelbine administered with two different schedules in patients with hormone receptor positive, HER2-negative advanced breast cancer (TempoBreast-1 trial)
CANCER RES. .. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS15-OT3-02-04
[Poster]
Web of Science
FullText
FullText_MUG
** Pichler, P; Claes, N; Mazza, P; Zurawski, B; Potocki, P; Petru, E; Sediva, M; Katolicka, J; Lanza, F; Fontaine, C
Use of lipegfilgrastim in clinical practice for the prophylaxis of chemotherapy-induced neutropenia: interim results of pan-European non-interventional study
ANN ONCOL. 2016; 27:
Doi: 10.1093/annonc/mdw390.27
Web of Science
FullText
FullText_MUG
** Rinnerthaler, G; Gampenrieder, SP; Fridrik, M; Petzer, A; Hubalek, M; Petru, E; Jager, T; Andel, J; Balic, M; Ulmer, H; Mlineritsch, B; Greil, R
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS15-P1-13-10
[Poster]
Web of Science
FullText
FullText_MUG
** Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Mlineritsch, B; Greil, R
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw365.18
[Poster]
Web of Science
FullText
FullText_MUG
** Steger, G; Hubalek, M; Pfeiler, G; Greil, R; Ohler, L; Helfgott, R; Petru, E; Mraz, B; Hennebelle, M; Winiger, I; Gnant, M
STEPAUT: Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2-advanced breast cancer progressing on/after prior endocrine therapy, in routine clinical practice
EUR J CANCER. .. 2016; 57: S104-S105.
[Poster]
Web of Science
** Steger, G; Petru, E; Haslbauer, F; Egle, D; Galid, A; Sliwa, T; Lang, A; Kuhr, T; Petzer, A; Ruckser, R; Mlineritsch, B; Greil, R; Seifert, M; Singer, C; Andel, J; Kwasny, W; Marth, C; Pichler, P; Tinchon, C; Bartsch, R
Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw365.20
[Poster]
Web of Science
FullText
FullText_MUG
2015
Full paper/article (Journal)
** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.
Clin Chem. 2015; 61(6):838-849
Doi: 10.1373/clinchem.2014.234286
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Marth, C; Hubalek, M; Petru, E; Polterauer, S; Reinthaller, A; Schauer, C; Scholl-Firon, T; Singer, CF; Zschocke, J; Zeimet, AG
AGO Austria recommendations for genetic testing of patients with ovarian cancer.
Wien Klin Wochenschr. 2015; 127(15-16):652-654
Doi: 10.1007/s00508-015-0814-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mayer-Pickel, K; Petru, E; Mörtl, M; Pickel, H; Lang, U
Has there been a change in peripartal maternal mortality in a tertiary care obstetric European center over the last five decades?
Eur J Obstet Gynecol Reprod Biol. 2015; 185(1):145-150
Doi: 10.1016/j.ejogrb.2014.12.015
Web of Science
PubMed
FullText
FullText_MUG
** Pircher, M; Mlineritsch, B; Fridrik, MA; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Rinnerthaler, G; Ressler, S; Ulmer, H; Greil, R
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res. 2015; 35(1):517-21
Web of Science
PubMed
** Schwameis, R; Grimm, C; Petru, E; Natter, C; Staudigl, C; Lamm, W; Koelbl, H; Krainer, M; Brodowicz, T; Reinthaller, A; Polterauer, S
The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
PLoS One. 2015; 10(8):e0133838-e0133838
Doi: 10.1371/journal.pone.0133838
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C
Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Int J Gynecol Cancer. 2015; 25(2):257-262
Doi: 10.1097/IGC.0000000000000352
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Petru, E; Singer, CF; Polterauer, S; Galid, A; Schauer, C; Klocker, J; Seifert, M; Reinthaller, A; Benedicic, C; Hubalek, M; Hefler, L; Marth, C; Scholl-Firon, T; Bogner, G; Zeimet, AG
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.
Wien Med Wochenschr. 2015; 165(19-20):387-394
Doi: 10.1007/s10354-015-0392-3
Web of Science
PubMed
FullText
FullText_MUG
2014
Full paper/article (Journal)
** Heidary, M; Auer, M; Ulz, P; Heitzer, E; Petru, E; Gasch, C; Riethdorf, S; Mauermann, O; Lafer, I; Pristauz, G; Lax, S; Pantel, K; Geigl, JB; Speicher, MR
The dynamic range of circulating tumor DNA in metastatic breast cancer.
Breast Cancer Res. 2014; 16(4):421-421
Doi: 10.1186/s13058-014-0421-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Aigner, B; Bauernhofer, T; Petru, E; Niederkorn, A; Arzberger, EJ; Richtig, E
Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
Dermatology. 2014; 229(4):288-292
Doi: 10.1159/000365391
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Hrzenjak, A; Dieber-Rotheneder, M; Moinfar, F; Petru, E; Zatloukal, K
Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategies.
Cancer Lett. 2014; 354(1):21-27
Doi: 10.1016/j.canlet.2014.08.013
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, E; Taucher, V; Petru, E; Haybaeck, J
Targeted treatment of ovarian cancer--the multiple - kinase - inhibitor sorafenib as a potential option.
Anticancer Res. 2014; 34(4):1519-1530
Web of Science
PubMed
Abstract (Journal)
** Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Speicher, MR; Geigl, JB;
Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer.
EUR J CANCER. 2014; 50: S153-S153.-EACR; München.
Doi: 10.1016/S0959-8049(14)50562-X
[Oral Communication]
Web of Science
FullText
FullText_MUG
2013
Full paper/article (Journal)
** Heitzer, E; Auer, M; Hoffmann, EM; Pichler, M; Gasch, C; Ulz, P; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Mohan, S; Pristauz, G; Lackner, C; Höfler, G; Eisner, F; Petru, E; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.
Int J Cancer. 2013; 133(2):346-356
Doi: 10.1002/ijc.28030
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitzer, E; Lax, S; Lafer, I; Müller, SM; Pristauz, G; Ulz, P; Jahn, S; Högenauer, C; Petru, E; Speicher, MR; Geigl, JB
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.
BMC Med Genet. 2013; 14(1):129-129
Doi: 10.1186/1471-2350-14-129
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pachler, C; Knez, I; Petru, E; Dörfler, O; Vicenzi, M; Toller, W
Peripartum aortic dissection].
Anaesthesist. 2013; 62(4):293-295
Doi: 10.1007/s00101-013-2153-2
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, U; Harter, P; Hilpert, F; Mahner, S; Reuß, A; du Bois, A; Petru, E; Meier, W; Ortner, P; König, K; Lindel, K; Grab, D; Piso, P; Ortmann, O; Runnebaum, I; Pfisterer, J; Lüftner, D; Frickhofen, N; Grünwald, F; Maier, BO; Diebold, J; Hauptmann, S; Kommoss, F; Emons, G; Radeleff, B; Gebhardt, M; Arnold, N; Calaminus, G; Weisse, I; Weis, J; Sehouli, J; Fink, D; Burges, A; Hasenburg, A; Eggert, C
S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.
Geburtshilfe Frauenheilkd. 2013; 73(9):874-889
Doi: 10.1055/s-0033-1350713
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Wagner, U; Harter, P; Hilpert, F; Mahner, S; Reuss, A; du Bois, A; Petru, E; Meier, W; Ortner, P; Konig, K; Lindel, K; Grab, D; Piso, P; Ortmann, O; Runnebaum, I; Pfisterer, J; Luftner, D; Frickhofen, N; Grunwald, F; Maier, BO; Diebold, J; Hauptmann, S; Kommoss, F; Emons, G; Radeleff, B; Gebhardt, M; Arnold, N; Calaminus, G; Weisse, I; Weis, J; Sehouli, J; Fink, D; Burges, A; Hasenburg, A; Eggert, C;
S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours Short version 1.0-AWMF registration number: 032/035OL, June 2013.
GEBURTSH FRAUENHEILK. 2013; 73(9): 874-889.
Doi: 10.1055/s-0033-1350713
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Zeimet, AG; Reimer, D; Huszar, M; Winterhoff, B; Puistola, U; Azim, SA; Müller-Holzner, E; Ben-Arie, A; van Kempen, LC; Petru, E; Jahn, S; Geels, YP; Massuger, LF; Amant, F; Polterauer, S; Lappi-Blanco, E; Bulten, J; Meuter, A; Tanouye, S; Oppelt, P; Stroh-Weigert, M; Reinthaller, A; Mariani, A; Hackl, W; Netzer, M; Schirmer, U; Vergote, I; Altevogt, P; Marth, C; Fogel, M
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
J Natl Cancer Inst. 2013; 105(15): 1142-1150.
Doi: 10.1093/jnci/djt144
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Smolle, E; Taucher, V; Pichler, M; Petru, E; Lax, S; Haybaeck, J
Targeting signaling pathways in epithelial ovarian cancer.
Int J Mol Sci. 2013; 14(5):9536-9555
Doi: 10.3390/ijms14059536
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Speicher, MR; Geigl, JB
Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing
EUR J CANCER. 2013; 49: S399-S399.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
** Pircher, M; Mlineritsch, B; Fridrik, M; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Ressler, S; Rinnerthaler, G; Ulmer, H; Greil, R
Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy - A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie
ONKOLOGIE. 2013; 36: 159-159.
[Oral Communication]
Web of Science
2012
Full paper/article (Journal)
** Gnant, M; Balic, M; Petru, E; Raunik, W; Singer, CF; Steger, GG; Watzke, IM; Brodowicz, T
Treatment of Bone Metastases in Patients with Advanced Breast Cancer.
Breast Care (Basel). 2012; 7(2):92-98
Doi: 10.1159/000338650
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Petru, E; Zeimet, AG; Sevelda, P; Seifert, M; Singer, C; Hubalek, M; Angleitner-Boubenizek, L; Speiser, P; Benedicic, C; Stummvoll, W; Reinthaller, A; Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO)
Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer.
Wien Klin Wochenschr. 2012; 124(11-12):412-418
Doi: 10.1007/s00508-012-0185-2
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, D; Tamussino, K; Petru, E; Haas, J; Reich, O
Conization of the Uterine Cervix: Does the Level of Gynecologist's Training Predict Margin Status?
Int J Gynecol Pathol. 2012; 31(4):382-386
Doi: 10.1097/PGP.0b013e318242118c
Web of Science
PubMed
FullText
FullText_MUG
Correction
** Petru, E; Zeimet, AG; Sevelda, P; Seifert, M; Singer, C; Hubalek, M; Angleitner-Boubenizek, L; Speiser, P; Benedicic, C; Stummvoll, W; Reinthaller, A
Austrian Arbeitsgemeinschaft fur Gynakologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer (vol 124, pg 412, 2012)
WIEN KLIN WOCHENSCHR. 2012; 124(17-18): 669-669.
Doi: 10.1007/s00508-012-0231-0
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Abstract (Journal)
** Idris, T; Benedicic, C; Schest, E; Lang, U; Petru, E
Fulminant Course of Disease in primary Lungmetastases of a Trophoblast Tumor
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Idris, T; Volgger, B; Sallinger, G; Schauer, C; Pfleger, U; Neuwirth, M; Kreische, S; Marth, C; Petru, E
Non-acceptable Toxicity Profile in the randomized Phase-II-Study with liposomal Doxorubicin +/- Gemcitabine plus prophylactic G-CSF-Administration (AGO Austria 10) in platin-resistant Recurrent Ovarian Cancer
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Kolovetsiou-Kreiner, V; Benedicic, C; Tamussino, K; Petru, E
Prolonged clinical Response to Trabectedin in Platinum-refractory Carcinosarcoma of the Ovary: A Case Report
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Mayer-Pickel, K; Tamussino, K; Petru, E
Long-term Survival despite Platinum-refractory Recurrence following Ovarian Carcinoma: A Report on two Patients
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Schest, E; Idris, T; Benedicic, C; Lanz-Veit, A; Petru, E
4 Years of Tumor stabilization after early recurrence of cervical cancer in a 30-year-old woman
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Schest, E; Idris, T; Benedicic, C; Lanz-Veit, A; Tamussino, K; Petru, E
Long-term Remission following Treatment of a recurring Breast Cancer with palliative Radiation Therapy, Lapatinib and Fulvestrant: A Case Report
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Vergote, IB; Joly, F; Katsaros, D; Coens, C; Reinthaller, A; Hall, M; Steer, CB; Colombo, N; Lesoin, A; Casado, A; Petru, E; Green, J; Buck, M; Ray-Coquard, IL; Ferrero, A; Favier, L; Reed, N; Curve, H; Jimeno, A; Pujade-Lauraine, E;
Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A GCIG and EORTC-GCG study.
J CLIN ONCOL. 2012; 30(18):-48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); JUN 01-05, 2012; Chicago, IL.
[Oral Communication]
Web of Science
2011
Full paper/article (Journal)
** Greimel, E; Daghofer, F; Petru, E
Prospective assessment of quality of life in long-term ovarian cancer survivors.
Int J Cancer. 2011; 128(12): 3005-3011.
Doi: 10.1002/ijc.25642
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Harter, P; Sehouli, J; Reuss, A; Hasenburg, A; Scambia, G; Cibula, D; Mahner, S; Vergote, I; Reinthaller, A; Burges, A; Hanker, L; Pölcher, M; Kurzeder, C; Canzler, U; Petry, KU; Obermair, A; Petru, E; Schmalfeldt, B; Lorusso, D; du Bois, A
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO.
Int J Gynecol Cancer. 2011; 21(2):289-295
Doi: 10.1097/IGC.0b013e31820aaafd
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kurtz, JE; Kaminsky, MC; Floquet, A; Veillard, AS; Kimmig, R; Dorum, A; Elit, L; Buck, M; Petru, E; Reed, N; Scambia, G; Varsellona, N; Brown, C; Pujade-Lauraine, E; on behalf of Gynecologic Cancer Intergroup
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
ANN ONCOL. 2011; 22(11): 2417-2423.
Doi: 10.1093/annonc/mdr001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lee, CK; Gurney, H; Brown, C; Sorio, R; Donadello, N; Tulunay, G; Meier, W; Bacon, M; Maenpaa, J; Petru, E; Reed, N; Gebski, V; Pujade-Lauraine, E; Lord, S; Simes, RJ; Friedlander, M
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
BRIT J CANCER. 2011; 105(3): 360-365.
Doi: 10.1038/bjc.2011.256
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Full paper/article (Journal)
** Gainford, MC; Tinker, A; Carter, J; Petru, E; Nicklin, J; Quinn, M; Hammond, I; Elit, L; Lenhard, M; Friedlander, M
Malignant Transformation Within Ovarian Dermoid Cysts: An Audit of Treatment Received and Patient Outcomes. An Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Gynaecologic Cancer Intergroup (GCIG) Study
INT J GYNECOL CANCER. 2010; 20(1): 75-81.
Doi: 10.1111/IGC.0b013e3181c7fccf
Web of Science
FullText
FullText_MUG
Google Scholar
** Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Petru, E; Zatloukal, K; Denk, H
Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo.
Mol Cancer. 2010; 9(10): 49-49.
Doi: 10.1186/1476-4598-9-49
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Oneko, O; Petru, E; Masenga, G; Ulrich, D; Obure, J; Zeck, W
Management of the placenta in advanced abdominal pregnancies at an East african tertiary referral center.
J Womens Health (Larchmt). 2010; 19(7):1369-1375
Doi: 10.1089/jwh.2009.1704
Web of Science
PubMed
FullText
FullText_MUG
** Petru, E; Reinthaller, A; Angleitner-Boubenizek, L; Schauer, C; Zeimet, A; Dirschlmayer, W; Medl, M; Stummvoll, W; Sevelda, P; Marth, C
Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: results of an Austrian gynecologic oncologists' expert meeting.
WIEN KLIN WOCHENSCHR. 2010; 122(21-22): 649-652.
Doi: 10.1007/s00508-010-1483-1
Web of Science
PubMed
FullText
FullText_MUG
** Pristauz, G; Petru, E; Stacher, E; Geigl, JB; Schwarzbraun, T; Tsybrovskyy, O; Winter, R; Moinfar, F
Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.
Histopathology. 2010; 57(6):877-884
Doi: 10.1111/j.1365-2559.2010.03724.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Review
** Bjelic-Radisic, V; Petru, E
Hormonal contraception and breast cancer risk].
Wien Med Wochenschr. 2010; 160(19-20):483-486
Doi: 10.1007/s10354-010-0807-0
PubMed
FullText
FullText_MUG
** Petru, E
Changes of the FIGO Staging of Gynecologic Malignancies 2009
GEBURTSH FRAUENHEILK. 2010; 70(4): 269-272.
Doi: 10.1055/s-0029-1241020
Web of Science
FullText
FullText_MUG
** Petru, E; Stummvoll, W; Angleitner-Boubenizek, L; Scholl, T; Sevelda, P; Benedicic, C; Speiser, P; Reinthaller, A
A Literature Review-Based Clinical Guide on the Use of Erythropoiesis-Stimulating Agents (ESA) in the Treatment of Patients with Gynaecological Malignancies and Related Anaemia
GEBURTSH FRAUENHEILK. 2010; 70(8): 646-657.
Doi: 10.1055/s-0030-1250229
Web of Science
FullText
FullText_MUG
** Pristauz, G; Geigl, JB; Petru, E
BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer.
Wien Med Wochenschr. 2010; 160(7-8): 158-162.
Doi: 10.1007/s10354-010-0772-7
PubMed
FullText
FullText_MUG
Case Report
** Idris, T; Krippl, P; Lang, U; Petru, E
Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer.
Breast Care (Basel). 2010; 5(5):335-337
Doi: 10.1159/000321394
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Begusch, S; Petru, E
Endometrium carcinoma with deep fibroids trane invasion : experiance with 241 patients with endometroid subtype
GEBURTSH FRAUENHEILK. 2010; 70(3):242-243.
[Keynote lecture]
Web of Science
** Bjelic-Radisic, V; Petru, E
Hormonal contraception and breast cancer risk - overview in literature
GEBURTSH FRAUENHEILK. 2010; 70(3):243-243.
[Keynote lecture]
Web of Science
** Einwagner, K; Petru, E
Small cell neuroendocrine cancer of ovars
GEBURTSH FRAUENHEILK. 2010; 70(3):245-245.
[Keynote lecture]
Web of Science
** Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Petru, E; Zatloukal, K; Denk, H
Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
EJC SUPPL. 2010; 8(5): 248
Doi: 10.1016/S1359-6349(10)71055-7
Web of Science
FullText
FullText_MUG
** Idris, T; Hartner, E; Krippl, P; Lang, U; Petru, E
Long-Tumorstabilisation a Her-2-neu positive, metastatic breast cancer patient with Lapatinib and Capecitabine.
GEBURTSH FRAUENHEILK. 2010; 70(5):P49-
[Keynote lecture]
Web of Science
** Idris, T; Hartner, E; Krippl, P; Lang, U; Petru, E
Long-tern survival of a Her-2-ner-positive breast cancer patients under the Lapatinic and Cepesitabin despite the various pretreatments
GEBURTSH FRAUENHEILK. 2010; 70(3): 244-244.
[Poster]
Web of Science
** Mayer-Pickel, K; Petru, E; Regitnig, P; Tamussino, K
Late isolated pelvic Lymp-node relapse after endometrium carcinoma on early stage
GEBURTSH FRAUENHEILK. 2010; 70(3):242-242.
[Keynote lecture]
Web of Science
** Pristauz, G; Petru, E; Stacher, E; Geigl, J; Speicher, M; Winter, R; Moinfar, F
Androgen receptor expression in patients with BRCA1/2-positive and BRCA1/2-negative breast cancer
GYNECOL ONCOL. 2010; 116(3):62-
[Keynote lecture]
Web of Science
** Pristauz, G; Petru, E; Stacher, E; Geigl, JB; Schwarzbraun, T; Tsybrovskyy, O; Winter, R; Moinfar, F
Expression of Androgen receptors in breast cancer patients after BRCA1 and BRCA 2 0-mutation test
GEBURTSH FRAUENHEILK. 2010; 70(3):244-244.-Jahrestagung der OEGGG; JUN 2-6, 2010; Zell am See, AUSTRIA.
[Poster]
Web of Science
** Pristauz, G; Petru, E; Stacher, E; Geigl, JB; Schwarzbraun, T; Tsybrovvskyy, O; Winter, R; Moinfar, F
Expression of Androgen receptors in Breast carcinomas of patients for BRCA1 and BRCA2 Mutation Testing.
GEBURTSH FRAUENHEILK. 2010; 70(5):P54-
[Keynote lecture]
Web of Science
** Radisic, VB; Petru, E
Hormonal Contraceptives and Breast Cancer Risk - Overview of the Literature
GEBURTSH FRAUENHEILK. 2010; 70(5):424-424.
[Keynote lecture]
Web of Science
** Schest, EC; Lackner, K; Lang, U; Petru, E
Kleinzelliges Endometriumkarzinom- Ein Fallbericht
GEBURTSH FRAUENHEILK. 2010; 70(3):242-242.-XIX Wissenschaftliche Tagung der AGO; 15.-17. April 2010; Salzburg.
[Keynote lecture]
Web of Science
** Schest, EC; Lackner, K; Lang, U; Petru, E
Small cell endometrial cancer - case report and Literature review.
GEBURTSH FRAUENHEILK. 2010; 70(5):P58-
[Keynote lecture]
Web of Science
** Steger, GG; Mlineritsch, B; Bartsch, R; Pluschnig, U; Petru, E; Peintinger, F; Sevelda, P; Greil, R
Non-pegylated liposomal doxorubicin in metastatic breast cancer (MBC) - Results from an Austrian post marketing surveillance programme
ONKOLOGIE. 2010; 33: 55-55.
[Keynote lecture]
Web of Science
** Ulrich, D; Petru, E; Gramm, S; Reich, O
Do we need a differentiated after-care for uterine stroma sarcomas?
Geburtsh Frauenheilk 2010; 3(70):242-242.-Annual meeting of the Society for Gynecologic Oncology; APR 15-17, 2010; Salzburg, Austria.
[Poster]
Web of Science
2009
Full paper/article (Journal)
** Idris, T; Winter, R; Lang, U; Petru, E
Topotecan-induced long-term remission of an advanced endometrial cancer after treatment with cisplatinum, an anthracycline and paclitaxel.
ANTICANCER RES. 2009; 29(5): 1761-1762.
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
Google Scholar
** Petru, E; Wildt, L; Stummvoll, W; Singer, C; Speiser, P; Fischerlehner, G; Reitsamer, R; Kubista, E; Marth, C; Winter, R; Menzel, C; Leodolter, S; Seifert, M; Zervomanolakis, I; Zeimet, A; Reinthaller, A
Consensus of the Austrian Society for Gynecology and Obstetrics/Gynecologic Oncology Working Group Fertility, Contraception and Hormone Replacement Therapy in Oncologic Patients with Special Reference to Breast Cancer
GEBURTSH FRAUENHEILK. 2009; 69(12): 1071-1077.
Doi: 10.1055/s-0029-1240642
Web of Science
FullText
FullText_MUG
Google Scholar
** Pristauz, G; Winter, R; Fischerauer, E; Haas, J; Bjelic-Radisic, V; Bader, AA; Petru, E
Can routine gynecologic examination contribute to the diagnosis of cervical involvement by primary endometrial cancer?
EUR J GYNAECOL ONCOL. 2009; 30(5): 497-499.
Web of Science
PubMed
Google Scholar
Abstract (Journal)
** Beganovic, S; Haas, J; Benedicic, C; Petru, E
Age and LDH-Value as factors for Forecasts in a case of ovarian carcinoma sarcoma
GEBURTSH FRAUENHEILK. 2009; 69(3):1-
[Oral Communication]
Web of Science
** Petru, E; Sampl, E; Haas, J; Benedicic, C; Winter, R
Comparison of tumour size and metastases in stage I and III primary epithelial ovarian cancer
EJC SUPPL. 2009; 7(2):456-457.-Joint ECCO 15 34th ESMO Multidisciplinary Congress; SEP 20-24, 2009; Berlin, Germany.
Doi: 10.1016/S1359-6349(09)71546-0
[Poster]
Web of Science
FullText
FullText_MUG
** Sampl, E; Haas, J; Winter, R; Petru, E
Comparison of primary tumour size and metastasis size in the Stage I and III of epithelial ovary carcinoma
GEBURTSH FRAUENHEILK. 2009; 69(3):4-
[Keynote lecture]
Web of Science
News-Item
** Petru, E; Luck, HJ; Stuart, G; Gaffney, D; Millan, D; Vergote, I
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.
EUR J OBSTET GYN REPROD BIOL. 2009; 143(2): 69-74.
Doi: 10.1016/j.ejogrb.2008.12.015
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Full paper/article (Proceedings)
** Zeimet, AG; Reimer, D; Radl, AC; Reinthaller, A; Schauer, C; Petru, E; Concin, N; Braun, S; Marth, C
Pros and Cons of Intraperitoneal Chemotherapy in the Treatment of Epithelial Ovarian Cancer
ANTICANCER RES. 2009; 29(7): 2803-2808.
[Keynote lecture]
Web of Science
Google Scholar
2008
Full paper/article (Journal)
** Kroiss, R; Winkler, V; Kalteis, K; Bikas, D; Rudas, M; Tea, M; Fuerhauser, C; Muhr, D; Cerny, H; Glueck, S; Petru, E; Concin, H; Kubista, E; Oefner, P; Wagner, T
Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group.
J Cancer Res Clin Oncol. 2008; 134(10):1113-1121
Doi: 10.1007/s00432-008-0383-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Ludwig, H; Auberger, T; Burghuber, OCh; Gnant, M; Hopfinger, G; Jäger, U; Keil, F; Kornek, G; Linkesch, W; Petru, E; Pirker, R; Pittermann, E; Reinthaller, A; Samonigg, H; Steger, G; Stockenhuber, F; Studnicka, M; Weiss, G; Zielinski, C
The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases
Wien Klin Wochenschr. 2008; 120(15-16): 507-513.
Doi: 10.1007/s00508-008-1007-4
Web of Science
PubMed
FullText
FullText_MUG
** Petru, E; Andel, J; Angleitner-Boubenizek, L; Steger, G; Bernhart, M; Busch, K; Gehmacher, O; Hernler, T; Kastner, U; Lanz-Veit, A; Pluschnigg, U; Polachova, J; Rohde, M; Schiller, L; Schramböck, R; Stangl, W; Thödtmann, R; Zabernigg, A
Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy.
Wien Med Wochenschr. 2008; 158(5-6): 169-173.
Doi: 10.1007/s10354-008-0515-1
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Benedicic, C; Kimmig, R; Marth, C
Early ovarian cancer (FIGO stage I-IIA)
ONKOLOGE. 2008; 14(11): 1130-+.
Doi: 10.1007/s00761-008-1472-4
Web of Science
FullText
FullText_MUG
** Schneuber, SE; Scholz, HS; Regitnig, P; Petru, E; Winter, R
Breast metastasis 56 months before the diagnosis of primary ovarian cancer: a case study.
ANTICANCER RES. 2008; 28(5B): 3047-3050.
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
Google Scholar
** Volgger, B; Petru, E; Angleitner-Boubenizek, L; Weigert, M; Reinthaller, A; Lass, H; Stempfl, A; Gamper, C; Deibl, M; Marth, C
Erythropoetin beta Twice Weekly Versus Standard Therapy in Patients with Gynaecological Malignancies - A Randomised Austrian AGO Trial
ANTICANCER RES. 2008; 28(6B): 3977-3984.
Web of Science
Editorial
** Diel, I
Breast Cancer After Care Treatments
BREAST CARE. 2008; 3(5): 357-363.
Doi: 10.1159/000158574
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Correspondence
** Petru, E
Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients by Rocconi et al.
Gynecol Oncol. 2008; 111(1): 159-160.
Doi: 10.1016/j.ygyno.2008.06.005
Web of Science
PubMed
FullText
FullText_MUG
2007
Full paper/article (Journal)
** Bader, AA; Petru, E; Winter, R
Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy.
Gynecol Oncol. 2007; 105(1):269-272
Doi: 10.1016/j.ygyno.2007.01.009
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bader, AA; Schlembach, D; Tamussino, KF; Pristauz, G; Petru, E
Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
Lancet Oncol. 2007; 8(1):79-81
Doi: 10.1016/S1470-2045(06)71014-2
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Zeck, W; Kelters, I; Winter, R; Lang, U; Petru, E
Lessons learned from four advanced abdominal pregnancies at an East African Health Center.
J Perinat Med. 2007; 35(4):278-281
Doi: 10.1515/JPM.2007.075
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Petru, E; Angleitner-Boubenizek, L; Reinthaller, A; Volgger, B; Kohlberger, P; Deibi, M; Bogner, G; Wolfram, G; Marth, C
Early termination of a phase II study of the Austrian AGO: Weekly docetaxel and irinotecan in platinum-refractory and resistant ovarian cancer
EJC SUPPL. 2007; 5(4):319-319.
Doi: 10.1016/S1359-6349(07)71201-6
[Keynote lecture]
Web of Science
FullText
FullText_MUG
** Petru, E; Angleitner-Boubenizek, L; Reinthaller, A; Volgger, B; Kohlberger, P; Marth, C
Weekly Docetaxel and irinotecan in platin-refractory and -resistant ovarian cancer - A multicentre phase II study of the Austrian AGO
GEBURTSH FRAUENHEILK. 2007; 67(5):504-505.
[Keynote lecture]
Web of Science
** Pristauz, G; Bjelic-Radisic, V; Fischerauer, E; Winter, R; Petru, E
Clinical manifestation of the cervical infestation in primary endometrial cancer
GEBURTSH FRAUENHEILK. 2007; 67(5):526-527.-Gem.Tagung Bayerische Gesellschaft für Geburtshilfe und Frauenheilkunde und Österreichische Gesellschaft für Gynäkologie und Geburtshilfe ; JUNE 7 - 9, 2007; München, Germany.
[Oral Communication]
Web of Science
** Trutnovsky, G; Haas, J; Petru, E; Greimel, E
Influence of pregnancy and birth on body sensation and sexuality in women
GEBURTSH FRAUENHEILK. 2007; 67(5):550-550.
[Keynote lecture]
Web of Science
2006
Full paper/article (Journal)
** Bader, AA; Winter, R; Moinfar, F; Petru, E; Pristauz, G; Scholz, HS; Haas, J; Tamussino, KF
Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer?
Gynecol Oncol. 2006; 103(1):106-112
Doi: 10.1016/j.ygyno.2006.01.051
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bjelic-Radisic, V; Stöger, H; Winter, R; Beham-Schmid, C; Petru, E
Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report.
Anticancer Res. 2006; 26(2B):1627-1630
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
Google Scholar
** Leibl, S; Bodo, K; Gogg-Kammerer, M; Hrzenjak, A; Petru, E; Winter, R; Denk, H; Moinfar, F
Ovarian granulosa cell tumors frequently express EGFR (Her-1), Her-3, and Her-4: An immunohistochemical study.
Gynecol Oncol. 2006; 101(1): 18-23.
Doi: 10.1016/j.ygyno.2005.10.009
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Marth, C; Windbichler, GH; Hausmaninger, H; Petru, E; Estermann, K; Pelzer, A; Mueller-Holzner, E
Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study.
Int J Gynecol Cancer. 2006; 16(4): 1522-1528.
Doi: 10.1111/j.1525-1438.2006.00622.x
Web of Science
PubMed
FullText
FullText_MUG
** Petru, E; Angleitner-Boubenizek, L; Reinthaller, A; Deibl, M; Zeimet, AG; Volgger, B; Stempfl, A; Marth, C
Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study.
Gynecol Oncol. 2006; 102(2):226-229
Doi: 10.1016/j.ygyno.2005.12.017
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Trutnovski, G; Haas, J; Lang, U; Petru,E
Women's perception of sexuality during pregnancy and after birth.
AUST N Z J OBSTET GYNAECOL. 2006; 46(4): 282-287.
Doi: 10.1111/j.1479-828X.2006.00592.x
Web of Science
PubMed
FullText
FullText_MUG
** Zeck, W; Bjelic, V; Petru, E; Lang, U
Delivery of a healthy twin after intrauterine demise and expulsion of a first twin.
J Obstet Gynaecol Res. 2006; 32(5):517-519
Doi: 10.1111/j.1447-0756.2006.00440.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Zeck, W; Kelters, I; Lang, U; Petru, E
Lessons learned from maternal deaths at an East African health center.
J Perinat Med. 2006; 34(6):459-461
Doi: 10.1515/JPM.2006.090
Web of Science
PubMed
FullText
FullText_MUG
Correspondence
** Petru, E; Benedicic, Ch; Huell, A
Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
GYNECOL ONCOL. 2006; 102: 129-129.
Doi: 10.1016/j.ygyno.2006.02.021
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Comment
** Petru, E; Moinfar, F; Graf, S
Regulation of the E2F family: a further step in understanding ovarian cancer biology.
Cancer Biol Ther. 2006; 5(7):777-778
Doi: 10.4161/cbt.5.7.3020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2005
Full paper/article (Journal)
** Kapp, KS; Poschauko, J; Tauss, J; Berghold, A; Oechs, A; Lahousen, M; Petru, E; Winter, R; Kapp, DS
Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Int J Radiat Oncol Biol Phys. 2005; 62(5):1399-1404
Doi: 10.1016/j.ijrobp.2004.12.037
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Correspondence
** Petru, E; Petru, C; Benedicic, Ch
Re: Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
GYNECOL ONCOL. 2005; 96(2): 559; author reply 559-559; author reply 560.
Doi: 10.1016/j.ygyno.2004.09.060
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Petru, E; Angleitner-Boubenizek, L; Reinthaller, A; Zeimet, AG; Stempfl, A; Volgger, B; Deibl, M; Denison, U; Bogner, G; Marth, C
Phase II Austrian AGO study of pegylated liposomal doxorubicin and gemcitabine in platinum-refractory and resistant ovarian cancer following previous platinum-taxane therapy
EJC SUPPL. 2005; 3(2): 266-267.
Web of Science
2004
Full paper/article (Journal)
** Petru, E; Schwarz, S; Benedicic, C; Reuss, J; Haas, J; Winter, R
Goserelin as palliative treatment in ovarian and endometrial carcinoma
GEBURTSH FRAUENHEILK. 2004; 64: 831-834.
Doi: 10.1055/s-2004-821148
Web of Science
FullText
FullText_MUG
** Scholz, HS; Petru, E; Tamussino, K; Winter, R
Wound rupture after Misgav-Ladach cesarean section: a case report
Gynakol Geburtshilfliche Rundsch. 2004; 44(4): 238-239.
Doi: 10.1159/000079715
(- Case Report)
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Petru, E; Klein, V; Kapp, K; Haas, J; Pickel, H; Benedicic, C; Reuss, J; Winter, R
Anemia and prognosis of cervical cancer following radical hysterectomy
ANN ONCOL. 2004; 15: 135-136.
Web of Science
2003
Full paper/article (Journal)
** Petru, E; Benedicic, Ch; Seewann, A; Pickel, H
Palliative cytostatic treatment of cervical carcinoma.
Eur J Gynaecol Oncol. 2003; 24(6):473-474
Web of Science
PubMed
Google Scholar
** Petru, E; Kurschel, S; Walsberger, K; Haas, J; Tamussino, K; Winter, R
Can bowel endoscopy predict colorectal surgery in patients with an adnexal mass?
INT J GYNECOL CANCER 2003 13: 292-296.
Doi: 10.1046%2Fj.1525-1438.2003.13191.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Short report/Letter
** Petru, E; Herzog, K; Kurschel, S; Tamussino, K; Winter, R
Vesicocutaneous fistula mimicking an abdominal wall abscess 2 years after radical abdominal hysterectomy.
GYNECOL ONCOL 2003 90: 494-494.
Doi: 10.1016%2FS0090-8258%2803%2900291-9
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2002
Full paper/article (Journal)
** Bader, AA; Tio, J; Petru, E; Bühner, M; Pfahlberg, A; Volkholz, H; Tulusan, AH
T1 breast cancer: identification of patients at low risk of axillary lymph node metastases.
Breast Cancer Res Treat. 2002; 76(1):11-17
Doi: 10.1023%2FA%3A1020231300974
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Benedicic, C; Petru, E; Scholz, HS; Winter, R
Tarsal metastasis as the primary manifestation of endometrial cancer. A case report
GEBURTSH FRAUENHEILK 2002 62: 179-180.
Doi: 10.1055/s-2002-22114
Web of Science
FullText
FullText_MUG
** Giuliani, A; Tamussino, K; Basver, A; Haas, J; Petru, E
The impact of body mass index and weight gain during pregnancy on puerperal complications after spontaneous vaginal delivery
WIEN KLIN WOCHENSCHR. 2002; 114(10-11): 383-386.
Web of Science
Google Scholar
** Kapp, KS; Poschauko, J; Geyer, E; Berghold, A; Oechs, AC; Petru, E; Lahousen, M; Kapp, DS
Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy.
INT J RADIAT ONCOL BIOL PHYS, 54, 58-66, 0360-3016
Doi: 10.1016/S0360-3016(02)02896-1
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Peters-Engl, C; Medl, M; Denison, U; Sevelda, P; Leodolter, S; Petru, E
Does long-term application of granulocyte colony-stimulating factor adversely influence overall survival in patients with ovarian cancer? A clinical study.
ANTICANCER RES. 2002; 21(5): 3701-3706.
Web of Science
PubMed
** Scholz, HS; Arikan, MG; Benedicic, C; Petru, E; Haas, J; Weiss, PA
Outcome of pregnancies after non-amniocentesis-induced premature rupture of membranes at 14 to 23 weeks' gestation.
Wien Klin Wochenschr. 2002; 114(1-2):50-53
Web of Science
PubMed
Google Scholar
** Scholz, HS; Benedicic, C; Haas, J; Tamussino, K; Petru, E
Stage IV ovarian cancer: prognostic factors and survival beyond 5 years.
ANTICANCER RES. 2002; 21(5): 3729-3732.
Web of Science
PubMed
** Scholz, HS; Lax, S; Petru, E; Benedicic, C; Winter, R
Inguinal lymph node metastasis as the presenting symptom of endometrial cancer: a case report.
Anticancer Res. 2002; 22(4):2531-2532
(- Case Report)
Web of Science
PubMed
Google Scholar
** Scholz, HS; Petru, E; Benedicic, C; Haas, J; Tamussino, K; Winter, R
Fibrin application for preventing lymphocysts after retroperitoneal lymphadenectomy in patients with gynecologic malignancies.
Gynecol Oncol. 2002; 84(1):43-46
Doi: 10.1006/gyno.2001.6462
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Winter, R; Haas, J; Reich, O; Koemetter, R; Tamussino, K; Lahousen, M; Petru, E; Pickel, H
Parametrial spread of cervical cancer in patients with negative pelvic lymph nodes.
Gynecol Oncol. 2002; 84(2):252-257
Doi: 10.1006/gyno.2001.6495
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Zehetleitner, G; Thiel, I; Petru, E
Long-term disease-free survival after breast cancer metastatic to the ovary.
Int J Gynecol Cancer. 2002; 12(3):317-318
Doi: 10.1046/j.1525-1438.2002.t01-2-01126.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2001
Full paper/article (Journal)
** Bodner, K; Bodner-Adler, B; Obermair, A; Windbichler, G; Petru, E; Mayerhofer, S; Czerwenka, K; Leodolter, S; Kainz, C; Mayerhofer, K
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Gynecol Oncol. 2001; 81(2):160-165
Doi: 10.1006/gyno.2001.6152
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bodner-Adler, B; Bodner, K; Obermair, A; Czerwenka, K; Petru, E; Leodolter, S; Mayerhofer, K
Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
Anticancer Res. 2001; 21(4B):3069-3074
Web of Science
PubMed
Google Scholar
** Petru, E; Lax, S; Kurschel, S; Gücer, F; Sutter, B
Long-term survival in a patient with brain metastases preceding the diagnosis of endometrial cancer. Report of two cases and review of the literature.
J NEUROSURG 2001 94: 846-848.
Doi: 10.3171/jns.2001.94.5.0846
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Schmied, P; Petru, C
Complementary measures used by patients with gynecologic cancers undergoing cytotoxic or hormonal chemotherapy
GEBURTSH FRAUENHEILK 2001 61: 75-78.
Doi: 10.1055/s-2001-11165
Web of Science
FullText
FullText_MUG
** Scholz, HS; Benedicic, C; Arikan, MG; Haas, J; Petru, E
Spontaneous vaginal delivery in the birth-chair versus in the conventional dorsal position: a matched controlled comparison.
Wien Klin Wochenschr. 2001; 113(17-18):695-697
Web of Science
PubMed
Google Scholar
** Scholz, HS; Lax, S; Tamussino, KF; Benedicic, C; Petru, E
Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.
ANTICANCER RES. 2001; 20(6C): 4801-4802.
(- Case Report)
Web of Science
PubMed
** Scholz, HS; Petru, E; Gücer, F; Haas, J; Tamussino, K; Winter, R
Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
ANTICANCER RES. 2001; 20(5C): 3983-3985.
Web of Science
PubMed
** Tamussino, KF; Gücer, F; Reich, O; Moser, F; Petru, E; Scholz, HS
Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma.
Int J Gynecol Cancer. 2001; 11(3):236-240
Doi: 10.1046%2Fj.1525-1438.2001.01024.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Zeilmann, W; Hittmair, A; Dietze, O; Petru, E
Primary malignant melanoma in a mature teratoma of the ovary: A case report
GEBURTSH FRAUENHEILK 2001 61: 517-519.
Doi: 10.1055/s-2001-15978
Web of Science
FullText
FullText_MUG
2000
Full paper/article (Journal)
** Arikan, GM; Scholz, HS; Petru, E; Haeusler, MC; Haas, J; Weiss, PA
Cord blood oxygen saturation in vigorous infants at birth: what is normal?
BJOG. 2000; 107(8):987-994
Doi: 10.1111/j.1471-0528.2000.tb10401.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Obermair, A; Petru, E; Windbichler, G; Peters-Engl, C; Graf, AH; Stummvoll, W; Kaider, A; Kurschel, S; Kölbl, H; Sevelda, P
Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer.
ONCOL REP 2000 7: 639-644.
Doi: 10.3892/or.7.3.639
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Kapp, K; Poschauko, J; Pickel, H
Primary concomitant chemo-radiotherapy for cervical carcinoma as a mew therapeutic standard replacing primary radiotherapy alone - A survey of randomized trials
GEBURTSH FRAUENHEILK 2000 60: 503-507.
Doi: 10.1055/s-2000-8029
Web of Science
FullText
FullText_MUG
Review
** Petru, E; Kurschel, S; Walsberger, K
Screening for endometrial carcinoma in asymptomatic women, including those receiving tamoxifen
GEBURTSH FRAUENHEILK 2000 60: 297-301.
Doi: 10.1055/s-2000-9535
Web of Science
FullText
FullText_MUG
1999
Full paper/article (Journal)
** Kapp, KS; Kapp, DS; Poschauko, J; Stücklschweiger, GF; Hackl, A; Pickel, H; Petru, E; Winter, R
The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.
Gynecol Oncol. 1999; 74(3):400-407
Doi: 10.1006/gyno.1999.5477
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Mayerhofer, K; Obermair, A; Windbichler, G; Petru, E; Kaider, A; Hefler, L; Czerwenka, K; Leodolter, S; Kainz, C
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.
Gynecol Oncol. 1999; 74(2):196-201
Doi: 10.1006/gyno.1999.5436
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Friedrich, G; Pickel, H; Lax, S; Beham, A
Life-threatening tracheal metastasis complicating ovarian cancer--a case report.
Gynecol Oncol. 1999; 74(1):141-142
Doi: 10.1006/gyno.1999.5383
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pickel, H; Lahousen, M; Petru, E; Stettner, H; Hackl, A; Kapp, K; Winter, R
Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer.
Gynecol Oncol. 1999; 72(2):215-219
Doi: 10.1006/gyno.1998.5184
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pöch, G; Vychodil-Kahr, S; Petru, E
Sigmoid model versus median-effect analysis for obtaining dose-response curves for in vitro chemosensitivity testing.
Int J Clin Pharmacol Ther. 1999; 37(4):189-192
Web of Science
PubMed
Google Scholar
** Scholz, HS; Haas, J; Petru, E
Do primiparas aged 40 years or older carry an increased obstetric risk?
PREV MED. 1999; 29(4): 263-266.
Doi: 10.1006/pmed.1999.0536
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Scholz, HS; Lax, S; Tamussino, KF; Petru, E
Inguinal lymph node metastasis as the only manifestation of lymphatic spread in ovarian cancer: A case report.
Gynecol Oncol. 1999; 75(3):517-518
Doi: 10.1006/gyno.1999.5592
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wagner, TM; Hirtenlehner, K; Shen, P; Moeslinger, R; Muhr, D; Fleischmann, E; Concin, H; Doeller, W; Haid, A; Lang, AH; Mayer, P; Petru, E; Ropp, E; Langbauer, G; Kubista, E; Scheiner, O; Underhill, P; Mountain, J; Stierer, M; Zielinski, C; Oefner, P
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
Hum Mol Genet. 1999; 8(3):413-423
Doi: 10.1093%2Fhmg%2F8.3.413
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Obermair, A; Petru, E; Windbichler, G; Peters-Engl, C; Graf, AH; Stummvoll, W; Kaider, A; Kurschel, S; Kolbl, H; Sevelda, P
Prognostic impact of tumor anemia in early-stage epithelial ovarian cancer
EUR J CANCER 1999 35: S233-S233.
Doi: 10.1016/S0959-8049(99)81333-1
Web of Science
FullText
FullText_MUG
1998
Full paper/article (Journal)
** Gücer, F; Moser, F; Tamussino, K; Reich, O; Haas, J; Arikan, G; Petru, E; Winter, R
Thrombocytosis as a prognostic factor in endometrial carcinoma.
Gynecol Oncol. 1998; 70(2):210-214
Doi: 10.1006/gyno.1998.5078
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gucer, F; Petru, E; Scholl, W
Malignancy Arising from Extraovarian Endometriosis - Objective
GEBURTSH FRAUENHEILK 1998 58: 33-37.
Doi: 10.1055/s-2007-1022117
Web of Science
FullText
FullText_MUG
** Gücer, F; Reich, O; Tamussino, K; Bader, AA; Pieber, D; Schöll, W; Haas, J; Petru, E
Concomitant endometrial hyperplasia in patients with endometrial carcinoma.
Gynecol Oncol. 1998; 69(1):64-68
Doi: 10.1006/gyno.1997.4911
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gucer, F; Tamussino, K; Panzitt, T; Taucher, A; Haas, J; Petru, E; Winter, R
Prognostic Implications of Thrombocytosis in Patients with Stage-III and Stage-IV Cervical-Cancer
INT J GYNECOL CANCER 1998 8: 369-373.
Doi: 10.1046/j.1525-1438.1998.09851.x
Web of Science
FullText
FullText_MUG
Google Scholar
** Kurschel, S; Petru, E; Luschin, G; Pickel, H
High-Risk Metastatic Choriocarcinoma - Are 2 Additional Chemotherapy Courses After a Complete Beta-hCG-Titer Remission Sufficient - A Case-Report
GEBURTSH FRAUENHEILK 1998 58: 51-53.
Doi: 10.1055/s-2007-1022120
Web of Science
FullText
FullText_MUG
** Lax, SF; Petru, E; Holzer, E; Pertl, AM; Ralph, G; Greenspan, DL; Berger, A; Jatzko, G
Mesenteric and Mesocolic Lymph-Node Metastases from Ovarian-Carcinoma - A Clinicopathological Analysis
INT J GYNECOL CANCER 1998 8: 119-123.
Doi: 10.1046/j.1525-1438.1998.09794.x
Web of Science
FullText
FullText_MUG
** Petru, E; Nagele, F; Czerwenka, K; Graf, AH; Lax, S; Bauer, M; Pehamberger, H; Vavra, N
Primary malignant melanoma of the vagina: long-term remission following radiation therapy.
Gynecol Oncol. 1998; 70(1):23-26
Doi: 10.1006/gyno.1998.4982
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Schöll, W; Gücer, F; Giuliani, A; Winter, R
Cervical cancer in pregnancy--practical recommendations
Gynakol Geburtshilfliche Rundsch. 1998; 38(2): 85-87.
Doi: 10.1159/000022238
Web of Science
PubMed
FullText
FullText_MUG
1997
Full paper/article (Journal)
** Luschinebengreuth, G; Petru, E; Mayer, R
Long-Term Remission of a Single Brain Metastasis Induced by Radiotherapy and 2nd-Line Emaco Chemotherapy - Case-Report
GEBURTSH FRAUENHEILK 1997 57: 477-478.
Doi: 10.1055/s-2007-1023121
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Marth, C; Windbichler, G; Petru, E; Dirschlmayer, W; Obermair, A; Czerwenka, K; Müller-Holzner, E; Dapunt, O
Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium.
GYNECOL ONCOL. 1997; 64: 121-125.
Doi: 10.1006/gyno.1996.4538
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Sevin, BU; Gottlieb, C
Radiosensitivity patterns of four human ovarian cancer cell lines in vitro.
Gynecol Oncol. 1997; 64(3):490-492
Doi: 10.1006/gyno.1996.4574
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Zehetleitner, G; Pickel, H
Preoperative Colposcopy Findings in Patients with Grade-III Cervical Intraepithelial Neoplasia (CIN-III)
GEBURTSH FRAUENHEILK 1997 57: 148-149.
Doi: 10.1055/s-2007-1023058
Web of Science
FullText
FullText_MUG
** Scholl, W; Haas, J; Giuliani, A; Petru, E; Tamussino, K; Gucer, F; Arikan, G; Winter, R
Prognosis of Invasive Cervical-Carcinoma in Pregnant Versus Nonpregnant Patients
GEBURTSH FRAUENHEILK 1997 57: 624-628.
Doi: 10.1055/s-2007-1023149
Web of Science
FullText
FullText_MUG
** Taus, P; Petru, E; Gucer, F; Pickel, H; Lahousen, M
Primary serous papillary carcinoma of the peritoneum: a report of 18 patients.
Eur J Gynaecol Oncol. 1997; 18(3):171-172
Web of Science
PubMed
Google Scholar
** Taus, P; Smola, M; Starz, I; Petru, E; Höfler, G; Kronberger, L
Primary malignant non-Hodgkin's lymphoma of the breast: breast preserving therapy in 3 patients
Gynakol Geburtshilfliche Rundsch. 1997; 37(2):68-70
Doi: 10.1159/000272834
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Kapp, DS; Kapp, KS; Stuecklschweiger, G; Poschauko, J; Pickel, H; Lahousen, M; Petru, E; Hackl, A
Significance of localized miliary subdiaphragmatic seeding and size of initial postsurgical residual in patients with epithelial ovarian cancer.
INT J RADIAT ONCOL BIOL PHYS 1997 39: 302-302.
Doi: 10.1016/S0360-3016(97)80890-5
Web of Science
FullText
FullText_MUG
1996
Full paper/article (Journal)
** Gucer, F; Arikan, MG; Petru, E; Mitterdofer, B; Lahousen, M; Lax, S
Diagnostic value of combined vaginal ultrasound and hysteroscopy in peri- and postmenopausal bleeding
Gynakol Geburtshilfliche Rundsch. 1996; 36(1):9-13
Doi: 10.1159/000272605
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Reich, O; Winter, R; Pickel, H; Tamussino, K; Haas, J; Petru, E
Does the Size of Pelvic Lymph-Nodes Predict Metastatic Involvement in Patients with Endometrial Cancer
INT J GYNECOL CANCER. 1996; 6: 445-447.
Doi: 10.1046/j.1525-1438.1996.06060445.x
Web of Science
FullText
FullText_MUG
1995
Full paper/article (Journal)
** Nagele, F; Petru, E; Medl, M; Kainz, C; Graf, AH; Sevelda, P
Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer.
Obstet Gynecol. 1995; 86(2):259-264
Doi: 10.1016%2F0029-7844%2895%2900126-C
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Haas, J; Schaider, H; Sevin, BU
Do cell cycle changes of human ovarian carcinoma cells after exposure to cytostatic drugs in vitro correlate with cytotoxicity?
GYNAKOL GEBURTSHILFL RUNDSCH. 1995; 35 Suppl 1: 15-18.
Doi: 10.1159/000272557
Web of Science
PubMed
FullText
FullText_MUG
** Petru, E; Sevin, BU; Haas, J; Ramos, R; Perras, J
A correlation of cell cycle perturbations with chemosensitivity in human ovarian cancer cells exposed to cytotoxic drugs in vitro.
Gynecol Oncol. 1995; 58(1):48-57
Doi: 10.1006/gyno.1995.1182
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schaider, H; Haberkorn, U; Petru, E; Berger, MR
Combination treatment based on metabolic effects of dinaline.
J Cancer Res Clin Oncol. 1995; 121(4):203-210
Doi: 10.1007%2FBF01366963
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1994
Full paper/article (Journal)
** Petru, E; Lahousen, M; Tamussino, K; Pickel, H; Stranzl, H; Stettner, H; Winter, R
Lymphadenectomy in stage I ovarian cancer.
Am J Obstet Gynecol. 1994; 170(2):656-662
Doi: 10.1016/S0002-9378(94)70244-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1993
Full paper/article (Journal)
** Girardi, F; Petru, E; Heydarfadai, M; Haas, J; Winter, R
Pelvic lymphadenectomy in the surgical treatment of endometrial cancer.
Gynecol Oncol. 1993; 49(2):177-180
Doi: 10.1006/gyno.1993.1103
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Luschinebengreuth, G; Petru, E; Pickel, H
Chemotherapy in Trophoblastic Tumors
ARCH GYNECOL OBSTET. 1993; 254: 1113-1115.
Doi: 10.1007/BF02266331
Web of Science
FullText
FullText_MUG
** Mayer, HO; Petru, E; Haas, J; Heydarfadai, M
Perioperative antibiotic prophylaxis in patients undergoing radical surgery for gynecologic cancer: single dose versus multiple dose administration.
Eur J Gynaecol Oncol. 1993; 14(3): 177-181.
PubMed
Google Scholar
** Petru, E; Heydarfadai, M; Lahousen, M; Pickel, H
Computed-Tomography in Preoperative Evaluation of Ovarian-Cancer
ARCH GYNECOL OBSTET. 1993; 254: 738-739.
Doi: 10.1007/BF02266159
Web of Science
FullText
FullText_MUG
Review
** Petru, E; Lahousen, M; Urdl, W; Luschin, G; Pickel, H
Hormone substitution in patients after primary treatment of gynecologic malignancies
Wien Med Wochenschr. 1993; 143(21): 539-541.
PubMed
1992
Full paper/article (Journal)
** Petru, E; Heydarfadai, M; Pickel, H; Lahousen, M; Tamussino, K
Primary, papillary serous carcinoma of the peritoneum; a report of experiences].
Geburtshilfe Frauenheilkd. 1992; 52(9):533-535
Doi: 10.1055/s-2007-1023175
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Lahousen, M; Pickel, H; Heydarfadai, M; Haas, J
Ovarian metastases of extragenital cancers
Gynakol Geburtshilfliche Rundsch. 1992; 32 Suppl 1(1): 135-135.
Doi: 10.1159/000271978
PubMed
FullText
FullText_MUG
** Petru, E; Lahousen, M; Pickel, H; Heydarfadai, M; Haas, J; Kleewein, P; Eibel, K
Prognostic factors in invasive squamous epithelial cancer of the vulva
Gynakol Geburtshilfliche Rundsch. 1992; 32 Suppl 1(1): 26-27.
Doi: 10.1159/000271926
PubMed
FullText
FullText_MUG
** Petru, E; Pickel, H; Heydarfadai, M; Lahousen, M
Remission induction with carboplatin-epirubicin-prednimustine followed by consolidation radiotherapy in advanced ovarian cancer.
INT J CLIN PHARM RES. 1992; 12(4): 205-207.
Web of Science
PubMed
Google Scholar
** Petru, E; Pickel, H; Heydarfadai, M; Lahousen, M; Haas, J; Schaider, H; Tamussino, K
Nongenital cancers metastatic to the ovary.
Gynecol Oncol. 1992; 44(1):83-86
Doi: 10.1016%2F0090-8258%2892%2990017-D
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Schmidt, F; Mikosch, P; Pickel, H; Lahousen, M; Tamussino, K; Grüendler, N; Posch, E
Abdominopelvic computed tomography in the preoperative evaluation of suspected ovarian masses.
Int J Gynecol Cancer. 1992; 2(5):252-255
Doi: 10.1046/j.1525-1438.1992.02050252.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1991
Full paper/article (Journal)
** Girardi, F; Petru, E; Haas, J
Lymph node status in corpus and cervix cancer
Gynakol Rundsch. 1991; 31 Suppl 2(10): 263-265.
Doi: 10.1159/000271760
PubMed
FullText
FullText_MUG
** Huober, J; Bertram, B; Petru, E; Kaufmann, M; Schmähl, D
Metabolism of debrisoquine and susceptibility to breast cancer.
Breast Cancer Res Treat. 1991; 18(1):43-48
Doi: 10.1007/BF01975442
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Boike, G; Sevin, BU; Petru, G
Methylxanthins Potentiate the Cytostatic Action of Cisplatin in Gynecological Cancer-Cells
ARCH GYNECOL OBSTET. 1991; 250: 112-113.
Doi: 10.1007/978-3-642-76124-9_55
Web of Science
FullText
FullText_MUG
** Petru, E; Pickel, H; Heydarfadai, M; Tamussino, K; Lahousen, M; Schaider, H
Experience with Stromal Tumors and Germ-Cell Tumors of the Ovary
INT J GYNECOL CANCER. 1991; 1: 9-14.
Doi: 10.1111/j.1525-1438.1991.tb00032.x
Web of Science
FullText
FullText_MUG
** Petru, E; Pickel, H; Lahousen, M; Heydarfadai, M; Auner, J
Para-aortic lymph node recurrence of struma tumors and germ cell tumors of the ovary
Gynakol Rundsch. 1991; 31 Suppl 2(3-4): 274-275.
Doi: 10.1159/000271764
PubMed
FullText
FullText_MUG
** Petru, E; Pickel, H; Tamussino, K; Lahousen, M; Heydarfadai, M; Posawetz, W; Jakse, R
Pretherapeutic scalene lymph node biopsy in ovarian cancer.
Gynecol Oncol. 1991; 43(3):262-264
Doi: 10.1016%2F0090-8258%2891%2990032-Z
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Schmähl, D
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Neoplasma. 1991; 38(2):147-155
Web of Science
PubMed
Google Scholar
** Pickel, H; Lahousen, M; Petru, E; Stettner, H
Sequential Chemotherapy Plus Radiotherapy for Ovarian-Cancer Following Radical Surgery
ARCH GYNECOL OBSTET. 1991; 250: 194-195.
Web of Science
** Pickel, H; Petru, E; Lahousen, M; Stettner, H; Heydarfadai, M; Arian-Schad, K; Hackl, A
Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer. A pilot study.
Am J Clin Oncol. 1991; 14(3):184-187
Doi: 10.1097/00000421-199106000-00002
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Winter, R; Petru, E; Lahousen, M; Haas, J
Postoperative Complications of Radical Abdominal Hysterectomy in Cervical-Carcinoma with Paraaortic Lymphadenectomy
ARCH GYNECOL OBSTET. 1991; 250: 140-141.
Doi: 10.1007/978-3-642-76124-9_74
Web of Science
FullText
FullText_MUG
1990
Full paper/article (Journal)
** Boike, GM; Petru, E; Sevin, BU; Averette, HE; Chou, TC; Penalver, M; Donato, D; Schiano, M; Hilsenbeck, SG; Perras, J
Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line.
Gynecol Oncol. 1990; 38(3):315-322
Doi: 10.1016/0090-8258(90)90065-S
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Boike, G; Sevin, BU
Potentiation of cisplatin cytotoxicity by methylxanthines in vitro.
J Cancer Res Clin Oncol. 1990; 116(5):431-433
Doi: 10.1007/BF01612988
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Pickel, H; Lahousen, M; Heydarfadai, M; Arian-Schad, K
[Toxicity of sequential chemo-radiotherapy in radically operated ovarian cancer].
Gynakol Rundsch. 1990; 30 Suppl 1(2):55-57
Doi: 10.1159/000271389
PubMed
FullText
FullText_MUG
Review
** Petru, E; Pickel, H; Lahousen, M; Boike, G; Heydarfadai, M
Combination chemotherapy in radically operated advanced ovarian cancer.
Cancer Treat Rev. 1990; 17(2-3):329-334
Doi: 10.1016%2F0305-7372%2890%2990065-N
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1989
Full paper/article (Journal)
** Auner, H; Petru, E; Hofmann, HM; Pickel, H; Pürstner, P
In vitro chemosensitivity testing in the treatment of ovarian carcinoma.
Arch Gynecol Obstet. 1989; 246(4):227-231
Doi: 10.1007/BF00934523
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Einspieler, C; Rosanelli, K; Gmoser, G; Heydarfadai, M; Kenner, T
Are there pre- or perinatal risk factors for sudden infant death?
GEBURTSH FRAUENHEILK. 1989; 49(5): 494-497.
Doi: 10.1055/s-2008-1036410
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Lahousen, M; Tamussino, K; Pickel, H; Stettner, H
Prognostic implications of residual tumour volume in stage III ovarian cancer patients undergoing adjuvant cytotoxic chemotherapy.
Baillieres Clin Obstet Gynaecol. 1989; 3(1):109-117
Doi: 10.1016/S0950-3552(89)80046-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Petru, E; Tamussino, K; Lahousen, M; Winter, R; Pickel, H; Haas, J
Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer.
Am J Obstet Gynecol. 1989; 161(4):937-941
Doi: 10.1016/0002-9378(89)90757-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pickel, H; Petru, E; Lahousen, M; Stettner, H; Lehnert, M
Efficacy of adjuvant carboplatin-epirubicin chemotherapy in advanced ovarian cancer after radical surgery.
Oncology. 1989; 46(4):222-225
Doi: 10.1159/000226720
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Walcher, W; Petru, E
The obstetric risk in adolescent primiparous females
GEBURTSH FRAUENHEILK. 1989; 49(5): 491-493.
Doi: 10.1055/s-2008-1036409
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** WALCHER, W; PETRU, E; TSCHERNE, G; TAMUSSINO, K
CHANGES IN THE OBSTETRICAL RISK OF ADOLESCENT PRIMIPARAS - A COMPARISON BETWEEN 1971-75 AND 1983-87
ADOLESCENT PEDIAT GYNECOL. 1989; 2: 221-223.
Doi: 10.1016/S0932-8610(19)80098-1
Web of Science
FullText
FullText_MUG
1988
Full paper/article (Journal)
** Hofmann, HM; Petru, E; Haas, J; Rollett, H; Pickel, H; Lahousen, M; Auner, H
Therapy of uterine cancer: a review
Gynakol Rundsch. 1988; 28 Suppl 2(4): 187-189.
Doi: 10.1159/000270816
PubMed
FullText
FullText_MUG
** Petru, E; Rosanelli, K; Einspieler, C; Auner, H; Heydarfadai, M
Perinatal stress factors and sudden infant death (SIDS)
Gynakol Rundsch. 1988; 28 Suppl 2(3): 131-132.
Doi: 10.1159/000270795
PubMed
FullText
FullText_MUG
** Winter, R; Petru, E; Haas, J
Pelvic and para-aortic lymphadenectomy in cervical cancer.
Baillieres Clin Obstet Gynaecol. 1988; 2(4):857-866
Doi: 10.1016/S0950-3552(98)80013-8
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Review
** Auner, H; Pürstner, P; Petru, E; Desoye, G; Lanzer, G; Urban, C; Schmid, H
Immunity of habitual abortion. Principles and current status of research
Gynakol Rundsch. 1988; 28 Suppl 2: 48-53.
Doi: 10.1159/000270773
PubMed
FullText
FullText_MUG